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ABSTRACT 
ABSTRACT 
Small molecule that target cellular DNA or proteins have become a subject of 
considerable interest. They serve as analogues in studies of protein-nucleic acid 
recognition, provide site-specific reagents for molecular biology, and yield rationales for 
new drug design. Transition metal complexes with their versatile structures, redox 
behaviour and physicochemical properties are found to be useful as highly sensitive 
diagnostic agents in chemotherapeutic applications. They interact with nucleic acids 
noncovalently by intercalation, groove binding and external electrostatic binding. The 
recognition of double helix DNA from a metal complex, is based on these non-covalent 
interactions and, the design and synthesis of suitable transition metal complexes as 
structural probes for nucleic acids has been an area of active research in the last decade. 
The binding studies of interaction of metal complex to the proteins and DNA are 
governed by a numbers of factors- ligand framework, choice of metal ion, redox behavior 
and spectroscopic properties, A variety of transition metal ions are available and are used 
by nature in the biological systems for molecular recognition and catalysis. This allows 
fine tuning of each of the interactions and opens the possibility of catalysis following 
recognition by the biological molecules. 
Recognition of the base pair sequence in the nucleic acids is one of the most challenging 
area as it provides clues to develop new chemotherapeutics. Considerable attention has 
been paid to design small molecule which are site specific and react at DNA sites in a 
sequence specific fashion. For example, the transition metal ions prefer to bind to N7 of 
guanine of DNA bases while the tin (IV) atom selectively binds to the phosphate moiety 
of the sugar backbone of DNA. Thus, there is an exigency to design and synthesize small 
molecules which are capable of selective binding. The recognition of peptides and 
proteins employing metal-ligand interaction are important viz. various transition metal 
ions (e.g., Cu^^ Ni^^, Zn^^ etc) bind to the imidazole side chains of surface exposed 
histidines of protein as this coordination interaction (M^^^his) has been used for protein 
purification by immobilized metal affinity chromatography, protein targeting to a surface, 
and two dimensional protein crystallization. 
Spectroscopic tools employed to study the interaction of the complexes with 
DNA/proteins [bovine milk casein (BMC) and human serum albumin (HSA)] were 
u.v.-vis spectroscopy, cyclic voltammetry, viscosity measurements. U.v.-vis spectroscopy 
is used more often as metal complexes have intense optical transitions in the visible 
region and the detection of absorption spectral changes on interaction with protein/DNA 
are quite evident. The kinetic studies are important to ascertain the mechanistic pathway 
of metal-protein/DNA interaction and throw light on their mode of binding. To 
authenticate the binding events of the complexes with protein/DNA, electrochemistry 
technique has been employed as it provides a complement to previously used methods of 
investigation such as u.v.-vis spectroscopy. The change in redox behaviour in these 
complexes is evidenced by sharp difference in voltammetric response before and after 
interaction with protein/DNA which is observed by recording cyclic voltammogram (c.v.) 
of all the free and bound species. The pattern of voltammetric responses suggest a 
mechanistic pathway for the coordination of these complexes with calf thymus DNA or 
proteins. To determine the mode of binding with calf thymus DNA, viscosity 
measurements are least ambiguous and most critical test of a binding model in solution in 
the absence of crystallographic structural data. Intercalation is expected to lengthen the 
DNA helix as the base pairs are pushed apart to accommodate the bound complex, 
leading to an increase in the DNA viscosity. In contrast, a partial, non-classical 
intercalation of complex could kink the DNA helix, reduce its effective length and 
concomitantly its viscosity. 
The l,2-bis(sulphapyridyl)oxamide ligand [L] and its complexes with Fe'", Co", Cu" and 
Zn" chloride were synthesized and characterized by elemental analyses, i.r., n.m.r., e.p.r. 
and u.v.-vis. spectroscopy and molar conductance measurements. Spectroscopic studies 
show that ail the complexes are octahedral and covaient. The electrochemical behavior of 
the Co" complex was monitored by cyclic voltammetry in a buffer/DMF solution (95:5). 
The E° values -0.622 V and -0.502 V reveal a reversible one electron redox wave 
attributed to a Co"/Co' redox couple at a scan rate of 0.1 Vs"'. The interaction of the Co" 
complex with bovine milk casein (BMC) was studied at the same scan rate which reveals 
a strong binding as the E*^  values shift to more negative potential = -0.908 V and 
-0.703 V). The cyclic voltammograms of the Co" complex bound by BMC were recorded 
at different pH's. The plot of E*^  versus pH showed that E° values are maximal at pH 7.4 
indicating good interaction between the BMC and the Co" complex which is further 
confirmed by kinetic data . 
ni 
The kinetic studies of the Co" complex bound to BMC was monitored in phosphate 
buffer solution at different pH's by spectrophotometry. The absorbance changes were 
monitored at 278 nm (Xmax for BMC) with respect to time and pseudo-first order rate 
constants, kobs, were obtained from the slope of the straight line using the least squares 
regression method. The plot of absorbance versus time at different pH's was linear up to 
80% completion of the reaction. The pH-rate profile data reveals that the reactions are pH 
dependent. 
In another set of experiments, template directed macrocyclic complexes having the 
composition [C,6H26N608Co]Cl2, [CigHzgNgOgNilCb, and [CisHseNeOsCuJCb were 
synthesized by the reaction of triethylene-tetraamine metal (Co", Ni" and Cu") 
complexes and oxamide ligand [2,2'-(oxalydimino)bis(diacefic acid)]. These complexes 
were characterized by elemental analyses, i.r., n.m.r., e.p.r. and u.v.-vis spectroscopy. All 
the complexes show square planar geometry and are ionic in nature. The kinetic studies 
of the Cu" complex were ascertained spectrophotometrically by observing the absorbance 
changes in presence of protein Human Serum Albumin (HSA) in phosphate buffer at 
different pH's at room temperature. The absorbance changes were monitored at 278 nm 
(Xmax of HSA) with respect to time and pseudo-first-order rate constants, kobs, were 
obtained from the slope of straight line using the least squares regression method. The 
plots of absorbance versus time at different pH's were linear upto 80% completion of the 
reaction. The electrochemical behavior of the Cu" complex was monitored by cyclic 
voltammetry in a buffer/water solution (5:95). The E" values -0.345 and -0.213 V 
IV 
respectively, were obtained at the scan rate of O.lVs"'. The interaction of the Cu" 
complex with the HSA was studied at the same scan rate, which reveals weak binding as 
the E° values do not shift considerably. The cyclic voltammogram of the Cu" complex 
bound to HSA was recorded at different pH's also (6.5 to 7.4). The pH-rate profile data 
reveals that the reactions are pH dependent. 
Heterobimetallic complexes have been extensively explored as biomodels, due to the 
presence of two metals in close proximity relevant to the active sites of bimetallic 
enzymes in the biological system. These complexes are very important in new generation 
pharmaceuticals. A new series of heterobimetallic complexes were synthesized by a well 
designed route. The ligand, dihydro OO'(salicylidene) 2,2' aminobenzothiazolyl borate 
was synthesized by condensation reaction of aminobenzothiazole and salicylaldehyde to 
give a Schiff base product which was allowed to react with KBH4 The ligand was 
metallated with Cu'VZn" and subsequently further metalloted with dimethyltindichloride 
to yield heterobimetallic complexes. All the complexes have been thoroughly 
characterized by elemental analysis, i.r., n.m.r., e.p.r. and u.v.-vis spectroscopy and 
conductance measurements. The spectroscopic data support square planar environment 
around Cu" atom while Sn'^ atom acquires penta-coordinate geometry. The interaction of 
complex [C34H32N4S203BCuSn2Cl5] with guanine, adenine and calf thymus DNA was 
studied by spectrophotometric, electrochemical and kinetic methods. The absorption 
spectra of complex [C34H32N4S203BCuSn2Cl5] exhibits a remarkable "hyperchromic 
effect" in presence of guanine and calf thymus DNA indicative of strong binding of the 
complex to calf thymus DNA preferentially through N7 position of guanine base while 
the adenine shows binding to a lesser extent. The kinetic data were obtained from the rate 
constants, kobs, values under pseudo-first order conditions. Cyclic voltammetry was 
employed to study the interaction of complex [C34H32N4S203BCuSn2Cl5] with guanine, 
adenine and calf thymus DNA. The c.v. of complex [C34H32N4S203BCuSn2Cl5] in 
absence and in presence of guanine and calf thymus DNA altered drastically with a 
positive shift in formal peak potential Epa and Epc value and a significant increase in peak 
current. The positive shift in formal potentials with increase in peak current favours 
strong interaction of complex [C34H32N4S203BCuSn2Cl5] with calf thymus DNA via. 
intercalation. The net shift in Ei/2 has been used to estimate the ratio of equilibrium 
constants for the binding of Cu(n) and Cu(I) complex to calf thymus DNA. 
Copper complexes containing heteroatoms have been shown to be useful probes of 
DNA duplexes. They show antibacterial activity by the hydrogen bond formation 
between the heteroatom of the complex and some bioreceptor of the ceils of bacteria 
which inhibit the synthesis of protein and synthesis of DNA in the cell nucleus. 
The ligand has been synthesized by the condensation reaction of 2-
mercaptobenzimidazole and diethyloxalate. The ligand was allowed to react with 
bis(ethylenediamine) Cu"/Ni" complexes and yield [C2oH22N8S2Cu]Cl2 and 
[C2oH22N8S2Ni]Cl2. These complexes were characterized by elemental analyses, i.r., 
n.m.r., e.p.r. and u.v.-vis spectroscopy and molar conductance measurements. On the 
basis of above studies, it has been concluded that all the complexes possess square-planar 
VI 
geometry and are ionic in nature. The binding of the complex [C2oH22NgS2Cu]Cl2 to calf 
thymus DNA have been investigated spectrophometrically, by cyclic voltammetric 
studies as well as viscosity measurements. The appearance of a large red shift (12 nm) 
with hypochromism in absorption spectra of the complex [C2oH22N8S2Cu]Cl2 in the 
presence of calf thymus DNA and increase in viscosity of calf thymus DNA indicates that 
the complex [C2oH22N8S2Cu]Cl2 binds to calf thymus DNA through an intercaiative 
mode. 
The electrochemical behaviour of the complex [C2oH22N8S2Cu]Cl2 in the presence and in 
the absence of calf thymus DNA in aqueous solution has been investigated by cyclic 
voltammetry. The cyclic voltammogram exhibits one quasi-reversible redox wave 
corresponding to Cu'VCu' redox couple with E1/2 value 27 mV at a scan rate of 0.2 Vs"'. 
The shift in AEp^  E1/2 and Ipa/Ipc values ascertain the interaction of calf thymus DNA with 
copper(ll) complex. The [C2oH22N8S2Cu]Cl2 complex and all the reactants were tested for 
antibacterial and antifungal studies. All the results show that the complex 
[C2oH22N8S2Cu]Cl2 is highly active against S. aureus and E. coli and also inhibits fungal 
growth (A. niger). 
vn 
PHYSICO-CHEMICAL AND BIOLOGICAL 
STUDIES ON NOVEL METAL COMPLEXES OF 
OXYGEN, NITROGEN AND SULPHUR 
CONTAINING LIGANDS 
THESIS 
for 
B o c t o r of ftilosfopljp 
IN 
CHEMISTRY 
BY 
DEPARTMENT OF CHEMISTRY 
ALIGARH MUSLIM UNIVERSITY 
ALIG/M^H (INDIA) 
T6071 
^ec[icate({ 
to 
9\iy (parents 
Dr. (Mrs.) Farukh Arjmand 
Department of Chemistry 
Aligarh Muslim University, Aligarh-202002, India 
E-mail: farukh_aijmand@yahoo.co.in 
Phone No. 0571-703893 
Certificate 
The work embodied in this thesis entitled "Physico-chemical and biological studies of 
novel metal complexes of oxygen, nitrogen and sulphur containing ligands" is the 
result of original research carried out by Miss. Bhawana Mohani under my 
supervision and is suitable for the award of Ph.D. degree. 
Farukh Arjmand 
CONTENTS 
ACKNOWLEDGEMENT 
PUBLICATIONS 
ABSTRACT 
Page No. 
I - V l l 
CHAPTER I: Introduction 1-36 
CHAPTER 11: Experimental 37-49 
CHAPTER III: Synthesis and characterization of new metal 50-67 
complexes of l,2-bis{sulphapyridyl)oxamide 
ligand. Kinetics and electrochemical studies 
of interaction of Co(ll) complex with bovine 
milk casein. 
CHAPTER IV: Template synthesis of Co(Il), Ni(II) and Cu(II) 68-87 
complexes derived from oxamide ligand and the 
reactivity of Cu(ll) complex towards human 
serum albumin. 
CHAPTER V: New borate complexes of dihydro OO'bis- 88-113 
(salicylidene) 2,2' aminobenzothiazolyl and the 
interaction of dimethyltin copper complex with 
guanine, adenine and calf thymus DNA. 
CHAPTER VI: Synthesis, characterization, of new Cu(II)/Ni(II) 114-137 
complexes of 2-mercaptobenzimidazole derivative. 
Antibacterial, antifungal and interaction of Cu(n) 
complex with calf thymus DNA 
REFERENCES: 138-166 
A CKNOWLEDGEMENTS 
Acknowledgements 
Starting by the name of almighty, the most gracious, who is the base of my every 
success and enabled me to complete this work. 
I take this great opportunity to express my deep sense of gratitude to my esteemed 
supervisor Dr. (Mrs.) Farukh Arjmand for her scholarly guidance, consecutive 
encouragement, keen interest, benediction and above alJ benevolent attitude. 
On record, I also place my gratitude to Dr. Sartaj Tabassum who supported and 
exhortation this effort in every way possible at the expense of his own important 
preoccupations. 
My thanks are also due to Chairman, Department of Chemistry for providing me the 
necessary facilities during the period my research work. 
My sincere thanks to R.S.I.C, C.D.R.I. Lucknow for providing I.R., C,H,N, analysis 
data & N.M.R. facility and IIT Mumbai for E.P.R. measurements. 
I am also greatful to Dr. Sudha Srivastava, TIFR, Mumbai and Prof R. J. Singh, 
Department of Physics, A.M.U., Aligarh for providing me the N.M.R. and E.P.R. facilities, 
respectively. 
I can not forget the valuable support of my parents and brothers also, who have always 
stood me with their constant support and invigoration throughout the research work 
At the last my loving thanks and best wishes to my laboratory colleagues for keeping 
my interest alive during the research. 
Bhawana Mohani 
PUBLICATIONS 
Publications 
1. New metal compounds and their reactivity towards bovine milk casein. 
Biiawana Mohani, Farukh Arjmand and Sartaj Tabassum, Transition Metal Chemistry, 
27, 776 (2002). 
2. Template synthesis of Co(II), Ni(II) and Cu(II) complexes derived from oxamide 
ligand and the reactivity of Cu(II) complex towards human serum albumin. 
Bhawana Mohani and Farukh Arjmand, Bioinorganic Chemistry and Applications 
(in press, 2004). 
3. New borate complexes of dihydro OO'bis(salicylidene) 2,2' aminobenzothiazolyl and 
the interaction of dimethyltin copper complex with guanine, adenine and calf thymus 
DNA. 
Farukh Arjmand, Bhawana Mohani and Shamima Parveen, Journal of Organometallic 
Chemistry (Communicated). 
4. Synthesis, characterization of new Cu(ll)/Ni(II) complexes of 
2-mercaptobenzimidazole derivatives. Antibacterial, antifungal and interaction of 
Cu(II) complex with calf thymus DNA. 
Bhawana Mohani and Farukh Arjmand, Journal of Pharmaceutical and Biomedical 
Analysis (Communicated). 
ABSTRACT 
ABSTRACT 
Small molecule that target cellular DNA or proteins have become a subject of 
considerable interest. They serve as analogues in studies of protein-nucleic acid 
recognition, provide site-specific reagents for molecular biology, and yield rationales for 
new drug design. Transition metal complexes with their versatile structures, redox 
behaviour and physicochemical properties are found to be useful as highly sensitive 
diagnostic agents in chemotherapeutic applications. They interact with nucleic acids 
noncovalently by intercalation, groove binding and external electrostatic binding. The 
recognition of double helix DNA from a metal complex, is based on these non-covalent 
interactions and, the design and synthesis of suitable transition metal complexes as 
structural probes for nucleic acids has been an area of active research in the last decade. 
The binding studies of interaction of metal complex to the proteins and DNA are 
governed by a numbers of factors- ligand framework, choice of metal ion, redox behavior 
and spectroscopic properties. A variety of transition metal ions are available and are used 
by nature in the biological systems for molecular recognition and catalysis. This allows 
fine tuning of each of the interactions and opens the possibility of catalysis following 
recognition by the biological molecules. 
Recognition of the base pair sequence in the nucleic acids is one of the most challenging 
area as it provides clues to develop new chemotherapeutics. Considerable attention has 
been paid to design small molecule which are site specific and react at DNA sites in a 
sequence specific fashion. For example, the transition metal ions prefer to bind to N? of 
guanine of DNA bases while the tin (IV) atom selectively binds to the phosphate moiety 
of the sugar backbone of DNA. Thus, there is an exigency to design and synthesize small 
molecules which are capable of selective binding. The recognition of peptides and 
proteins employing metal-ligand interaction are important viz. various transition metal 
ions (e.g., Cu^ '*^ , Ni^ "^ , Zn^ "^  etc) bind to the imidazole side chains of surface exposed 
histidines of protein as this coordination interaction (M''^-his) has been used for protein 
purification by immobilized metal affinity chromatography, protein targeting to a surface, 
and two dimensional protein crystallization. 
Spectroscopic tools employed to study the interaction of the complexes with 
DNA/proteins [bovine milk casein (BMC) and human serum albumin (HSA)] were 
u.v.-vis spectroscopy, cyclic voltammetry, viscosity measurements. U.v.-vis spectroscopy 
is used more often as metal complexes have intense optical transitions in the visible 
region and the detection of absorption spectral changes on interaction with protein/DNA 
are quite evident. The kinetic studies are important to ascertain the mechanistic pathway 
of metal-protein/DNA interaction and throw light on their mode of binding. To 
authenticate the binding events of the complexes with protein/DNA, electrochemistry 
technique has been employed as it provides a complement to previously used methods of 
investigation such as u.v.-vis spectroscopy. The change in redox behaviour in these 
complexes is evidenced by sharp difference in voltammetric response before and after 
interaction with protein/DNA which is observed by recording cyclic voltammogram (c.v.) 
of all the free and bound species. The pattern of voltammetric responses suggest a 
mechanistic pathway for the coordination of these complexes with calf thymus DNA or 
proteins. To determine the mode of binding with calf thymus DNA, viscosity 
measurements are least ambiguous and most critical test of a binding model in solution in 
the absence of crystallographic structural data. Intercalation is expected to lengthen the 
DNA helix as the base pairs are pushed apart to accommodate the bound complex, 
leading to an increase in the DNA viscosity. In contrast, a partial, non-classical 
intercalation of complex could kink the DNA helix, reduce its effective length and 
concomitantly its viscosity. 
The l,2-bis(sulphapyridyl)oxamide ligand [L] and its complexes with Fe'", Co", Cu" and 
Zn" chloride were synthesized and characterized by elemental analyses, i.r., n.m.r., e.p.r. 
and u.v.-vis. spectroscopy and molar conductance measurements. Spectroscopic studies 
show that all the complexes are octahedral and covalent. The electrochemical behavior of 
the Co" complex was monitored by cyclic voltammetry in a buffer/DMF solution (95:5). 
The E° values -0.622 V and -0.502 V reveal a reversible one electron redox wave 
attributed to a Co"/Co' redox couple at a scan rate of O.I Vs"'. The interaction of the Co" 
complex with bovine milk casein (BMC) was studied at the same scan rate which reveals 
a strong binding as the values shift to more negative potential (E° = -0.908 V and 
-0.703 V). The cyclic voltammograms of the Co" complex bound by BMC were recorded 
at different pH's. The plot of versus pH showed that E° values are maximal at pH 7.4 
indicating good interaction between the BMC and the Co" complex which is further 
confirmed by kinetic data . 
in 
The kinetic studies of the Co" complex bound to BMC was monitored in phosphate 
buffer solution at different pH's by spectrophotometry. The absorbance changes were 
monitored at 278 nm (A^ nax for BMC) with respect to time and pseudo-first order rate 
constants, kobs, were obtained from the slope of the straight line using the least squares 
regression method. The plot of absorbance versus time at different pH's was linear up to 
80% completion of the reaction. The pH-rate profile data reveals that the reactions are pH 
dependent. 
In another set of experiments, template directed macrocyclic complexes having the 
composition [CieHzeNfiOsCojCb, [CieHaeNeOgNijCb, and [CieHzeNeOgCuJClj were 
synthesized by the reaction of triethylene-tetraamine metal (Co", Ni" and Cu") 
complexes and oxamide ligand [2,2'-(oxalydimino)bis(diacetic acid)]. These complexes 
were characterized by elemental analyses, i.r., n.m.r., e.p.r. and u.v.-vis spectroscopy. All 
the complexes show square planar geometry and are ionic in nature. The kinetic studies 
of the Cu" complex were ascertained spectrophotometrically by observing the absorbance 
changes in presence of protein Human Serum Albumin (HSA) in phosphate buffer at 
different pH's at room temperature. The absorbance changes were monitored at 278 nm 
(Knax of HSA) with respect to time and pseudo-first-order rate constants, kobs, were 
obtained from the slope of straight line using the least squares regression method. The 
plots of absorbance versus time at different pH's were linear upto 80% completion of the 
reaction. The electrochemical behavior of the Cu" complex was monitored by cyclic 
voltammetry in a buffer/water solution (5:95). The E° values -0.345 and -0.213 V 
IV 
respectively, were obtained at the scan rate of O.lVs"'. The interaction of the Cu" 
complex with the HSA was studied at the same scan rate, which reveals weak binding as 
the E'^  values do not shift considerably. The cyclic voltammogram of the Cu" complex 
bound to HSA was recorded at different pH's also (6.5 to 7.4). The pH-rate profile data 
reveals that the reactions are pH dependent. 
Heterobimetallic complexes have been extensively explored as biomodels, due to the 
presence of two metals in close proximity relevant to the active sites of bimetallic 
enzymes in the biological system. These complexes are very important in new generation 
pharmaceuticals. A new series of heterobimetallic complexes were synthesized by a well 
designed route. The ligand, dihydro OO'(salicylidene) 2,2' aminobenzothiazolyl borate 
was synthesized by condensation reaction of aminobenzothiazole and salicylaldehyde to 
give a Schiff base product which was allowed to react with KBH4 The ligand was 
metallated with Cu'VZn" and subsequently further metallated with dimethyltindichloride 
to yield heterobimetallic complexes. All the complexes have been thoroughly 
characterized by elemental analysis, i.r., n.m.r., e.p.r. and u.v.-vis spectroscopy and 
conductance measurements. The spectroscopic data support square planar environment 
around Cu" atom while Sn'^ atom acquires penta-coordinate geometry. The interaction of 
complex [C34H32N4S203BCuSn2Cl5] with guanine, adenine and calf thymus DNA was 
studied by spectrophotometric, electrochemical and kinetic methods. The absorption 
spectra of complex [C34H32N4S203BCuSn2Cl5] exhibits a remarkable "hyperchromic 
effect" in presence of guanine and calf thymus DNA indicative of strong binding of the 
complex to calf thymus DNA preferentially through N? position of guanine base while 
the adenine shows binding to a lesser extent. The kinetic data were obtained from the rate 
constants, kobs, values under pseudo-first order conditions. Cyclic voltammetry was 
employed to study the interaction of complex [C34H32N4S203BCuSn2Cl5] with guanine, 
adenine and calf thymus DNA. The c.v. of complex [C34H32N4S203BCuSn2Cl5] in 
absence and in presence of guanine and calf thymus DNA altered drastically with a 
positive shift in formal peak potential Epa and Epc value and a significant increase in peak 
current. The positive shift in formal potentials with increase in peak current favours 
strong interaction of complex [C34H32N4S203BCuSn2Cl5] with calf thymus DNA via. 
intercalation. The net shift in E\a has been used to estimate the ratio of equilibrium 
constants for the binding of Cu(II) and Cu(l) complex to calf thymus DNA. 
Copper complexes containing heteroatoms have been shown to be useful probes of 
DNA duplexes. They show antibacterial activity by the hydrogen bond formation 
between the heteroatom of the complex and some bioreceptor of the cells of bacteria 
which inhibit the synthesis of protein and synthesis of DNA in the cell nucleus. 
The ligand has been synthesized by the condensation reaction of 2-
mercaptobenzimidazole and diethyloxalate. The ligand was allowed to react with 
bis(ethylenediamine) Cu"/Ni" complexes and yield [C2oH22N8S2Cu]Cl2 and 
[C2oH22NgS2Ni]Cl2. These complexes were characterized by elemental analyses, i.r., 
n.m.r., e.p.r. and u.v.-vis spectroscopy and molar conductance measurements. On the 
basis of above studies, it has been concluded that all the complexes possess square-planar 
VI 
geometry and are ionic in nature. The binding of the complex [C2oH22NgS2Cu]Cl2 to calf 
thymus DNA have been investigated spectrophometrically, by cyclic voltammetric 
studies as well as viscosity measurements. The appearance of a large red shift (12 nm) 
with hypochromism in absorption spectra of the complex [C2oH22N8S2Cu]Cl2 in the 
presence of calf thymus DNA and increase in viscosity of calf thymus DNA indicates that 
the complex [C2oH22N8S2Cu]Cl2 binds to calf thymus DNA through an intercalative 
mode. 
The electrochemical behaviour of the complex [C2oH22N8S2Cu]Cl2 in the presence and in 
the absence of calf thymus DNA in aqueous solution has been investigated by cyclic 
voltammetry. The cyclic voltammogram exhibits one quasi-reversible redox wave 
corresponding to Cu'VCu' redox couple with E1/2 value 27 mV at a scan rate of 0.2 Vs"'. 
The shift in AEp, E\a and Ipa/lpc values ascertain the interaction of calf thymus DNA with 
copper(ll) complex. The [C2oH22NgS2Cu]Cl2 complex and all the reactants were tested for 
antibacterial and antifungal studies. All the results show that the complex 
[C:oH22NgS2Cu]Cl2 is highly active against S. aureus and E. coli and also inhibits fungal 
growth (A. niger). 
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CHAPTER I 
INTRODUCTION 
INTRODUCTION 
The metal-DNA and metallo-protein interaction are of paramount importance as it is 
wellknown that DNA and proteins are the primary intracellular target for antitumor drugs 
in cancer chemotherapy [1-12]. Small molecule drugs interact with DNA, induce DNA 
damage which leads to the blockage of the cell division and eventually to the cell death 
[13,14], The cellular targets of many drugs used for treatment of disease are proteins 
[15,16]. It has been demonstrated in literature that replication and growth of cancerous 
cells can be prevented through the inhibition of transcription [17-20] within cells, the 
transcription of duplex DNA results in the formation of messenger RNA 
(mRNA), which is then translated into proteins (Figure 1). Therefore, inhibition of 
transcription is closely related to protein prototype [21]. 
DNA 
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RNA 
RNA splicing 
Soiice variants 
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Figure 1. One gene produce proteins with multiple functions. 
Most of the widely used antitumor drugs, including cisplatin, a well-known antitumor 
drug particularly used in treating small cell lung, ovarian, testicular, head and neck 
tumors [22] mitomycin C, actinomycin, anthracycline antibiotics utilize this mechanism 
as their mode of action [23-25]. 
The present study has been designed with the aim to evaluate the influence of new metal 
complexes, potential drug candidates on their biological targets DNA and proteins. 
Recent research reveals that many diseases including malignant lymphoma and cancer 
can be better understood at a molecular sequence lc\ el and thus many areas of medical 
science including diagnosis, therapy and prevention are changing dramatically [26]. To 
understand the specific target oriented drug binding, we cannot ignore the protein 
receptors which may either enhance or inhibit the activity of the drugs. Albumin is a 
major binding protein for drugs, only unbound or free drug is pharmacologically active as 
drugs exist in peripheral circulation as free (unbound) and protein-bound forms following 
the principle of reversible equilibrium and law of mass action (usually, therapeutic drug 
monitoring (TDM) measures total drug becausc there is equilibrium between bound and 
free drugs). Therefore, the concentration of free drug can be predicted from the 
concentration of total drug [27]. 
Transition metal ions copper(II), nickel(II) and zinc(n) bind to imidazole side chain of 
surface exposed histidines of proteins [28,30]. However, the binding to the protein activc 
site domain is stereospecific [31] as each protein has a unique pattern of histidine 
residues on the surface. This coordination interaction (M^"^-His) has been used for protein 
purification by immobilized metal affinity chromatography [32] protein targeting to a 
surface [33] and two-dimensional protein crystallization [34], Detailed structural 
information [35,36] on metallo-protein interaction can be helpful to design such 
complexes which maximize the contacts between a protein and a small molecule or 
alternatively, alter the chemical properties (for example, solubility) without disrupting 
binding. The same approach can be employed to design compounds with decreased 
affinity for human serum albumin. Compounds having reduced affinity for serum 
albumin can prove as potent drugs with significantly lower dosage levels and improved in 
vivo tolerances [37,38]. 
Human serum albumin (HSA) is the most abundant protein of blood serum at 
concentration of 0.63 mm [39]. It is a versatile carrier protein involved in the transport of 
hormones, vitamins, fatty acids, xenobiotics, drugs and metal ions including 
physiological calcium(II), zinc(II), cobalt(II), nickel(II) and copper(II) [40,41]. The 
variety of functions which HSA performs is made possible by the presence of many 
binding sites on the surface of HSA molecule including hydrophobic pockets of various 
sizes and shapes and coordination domains equipped with sets of donor groups 
appropriate for particular metals [42], 
In particular, the strong binding of copper(II) and nickel(II) at the N-terminus of HSA has 
been well characterized [43,44]. HSA's have six different lysine residues and one of 
these groups, Lys-199 is the most probable binding site for compounds [45] (Figure 2). 
X-ray crystallography and 'H NMR studies were used to investigate the metal binding 
sites on serum albumins [46-48]. However, HSA has never been co-crystallized with 
antitumor platinum group metallo-drugs or with any high affinity metal binding sites 
occupied, so the evidence for these interactions are mainly spectroscopic. 
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Figure 2. The environment of the Lysigg binding site in HSA as obtained directly from X-
ray refinement. Distances in A'^. 
Recently, cisplatin binding to HSA was studied by Sadler and co-workers [49]. A sulfur, 
nitrogen macrochelate, probably involving the surface-exposed Met-298 residue, 
accounts well for the shifts observed in the NMR spectra and this was speculated to be 
the main cisplatin binding site of HSA. On the other hand, the anti-arthritic gold 
compound auranofm triethylphosphine (2,3,4,6,-tetra-O-acetylglucopyranosato-S-) gold 
(1) was found to bind mainly to HSA. through formation of a Cys 34-S-Au bond [50]. 
The interactions between a number of rhodium(Il) complexes, ruthenium (HI) complexes 
and HSA have already been studied by means of spectroscopic and immunological 
techniques [51-53]. A direct dependence has been noted between the liposolubility of the 
metal complexes and several properties markedly their denaturing and Trp 214 
fluorescence quenching abilities [54] as well as their biological activities [55], 
Histidine (His) residues were earlier suggested as important coordination sites for these 
complexes [56], This interaction accounted well for the displacement of (he Rh-Rh 
absorption band from ca. 580 nm to 540 nm when rhodium complexes reacted with HSA. 
This was in accordance with the observations made for the interactions of HSA and 
ruthenium(lll) antitumor complexes where imidazole binding at His residues is usually 
suggested [57], Binding constants were measured by photometric method for interaction 
between albumin and the rhodium complex [Rh2(bridge)^]. where bridge == acctate (ac), 
propionate (pr), butyrate (but), trifluoroacetate (tfa) and trifluoroacetamidate (tfc) 
according to the following equation: 
HSA + [Rh2(bridge)4] ^ HSA:[Rh2(bridge),]. (1) 
For which is valid 
^ ^ CHSA[Rh2(tfc)4] 
Ch6A • C(Rj (t 
(2) 
(Ril2(tfc)4] 
A plot of l/(A-Ao) versus 1/Lo is linear, and the binding constant K was estimated from 
the ratio of the intercept to the slope [47], Where, AQ was the initial protein absorbance at 
the monitored wavelength (~500 nm), and therefore equal to zero. A was the recorded 
absorption for each increment in the complex concentration (LQ). This method has been 
employed for the determination of K for several drug-protein interactions and specifically 
to estimate K for the binding of cisplatin to HSA [58] (Figure 3). 
Thus, the pharmaco-kinetics and pharmaco-dynamics of any drug will depend, to a large 
extent, on the interaction with human serum albumin, the most abundant plasma protein 
[59]. The hypothesis of HSA acting as a "drug reservoir" for slow release of drugs has 
been already tested for cisplatin under clinical conditions [60,61]. 
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Figure 3. Plot ofl/(A-Ao) versus 1/Lo to the formation of adducts between rhodium(II) 
complexes and HSA. 
Casein is the major protein of bovine milk (which accoimts for 76-96% of total milk 
protein), a phosphoprotein, it exists as an equilibrium of soluble and complex colloidal 
aggregates (micelles) (Figure 4). The casein is solubilized by dialyzing skim milk against 
phosphate buffer or by dilution [62]. The casein behaves differently than most proteins. 
They have extremely flexible structures, there is no crystal data for the casein structure 
because the molecules do not form crystals. Recently, some researchers have studied the 
caseins using Raman spectroscopy. Thus secondary and tertiary structures in various 
casein were estimated [63]. 
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Figure 4a. Model of casein micelles proposed by Morr. 
Figure 4b. Model of casein micelles proposed by Waugh [64], 
Caseins have many unique properties, such as stabiHty to heating, high solution viscosity 
due to open, nearly random structure of casein molecules, melting properties under 
limited proteolysis, caseins become thermoplastic and flow upon heating. They have 
stable air cells, are quickly able to rearrange their structures and lower the interfacial free 
energy. The binding of cations, calcium(II), barium(II), strontium(II) to a, P- and k-casein 
was investigated to study binding domains in casein and strongest binding sites were 
observed for calcium(II) [64], Several studies have qualitatively assessed the binding of 
calcium(II) to caseins [65, 66] or individual caseins [67], 
In a recent study, it was found that a high molecular weight component of bovine skim 
milk binds bismuth ion, Bi^ "^  into the calcium sites and it can be used as a carrier of short-
lived bismuth isotopes ^^^Bi and ^'^Bi which have appHcation in radio-immuno therapy 
selective tumor destruction [68]. 
The interaction of transition metal complexes and DNA has been extensively studied, 
[69] mainly owing to their applications in pharmaceutical industries [70-76] as 
chemotherapeutic agents for the treatment of cancer [77-80], lymphomas, [81] acquired 
immunodeficiency syndrome (AIDS), anti HIV agents, [82-84] bacterial infections as 
well as the treatments of many other ailments [85,86]. 
There are number of modes through which small molecules such as metal complexes can 
interact with DNA [87-97]. These binding modes are (i) external binding by electrostatic 
attraction (ii) intercalation of planar aromatic molecules between the base pairs of the 
DNA helix (iii) major groove binding and minor-groove binding (Figure 5). The 
intercalation binding mode has been extensively studied and is rather well understood 
[98]. 
f ^ 
Figure 5 (i) external binding, (ii) intercalation (iii) groove binding 
Conventional intercalators are ethidium bromide, proflavin and base daunomycin [99] in 
which the planar fused aromatic ring systems can slip between adjacent base pairs of 
DNA without any major distortion from idealized-DNA form but binding of porphyrins 
to DNA involves a nonconventional intercalation mode as the porphyrin core is planar 
and is shielded by peripheral substituents [100], Crystallographic analysis of 
metalloporphyrin oligonucleotide complexes have shown that the intercalation or groove 
binding of cationic porphyrins causes a distortion of B-DNA significantly [101,102], 
9,10-Phenanthrenequinone diimine (phi) complexes of Rh(III) bind tightly to DNA 
through intercalation and serve as scaffolds for the molecular recognition of DNA 
functionalities [103,104], 
The crystal structure at high resolution reveals that phi complex of Rh(III) bound site-
specifically to a DNA octamer [105], Similar binding modes have been studied in three 
ligand a-diimine iridium complexes Ir(phi(bpy)(phen)^'^ [106], This species can be 
resolved into its A- and A- isomers and provides a convenient electrochemical probe of 
electron transfer through the DNA double helix. 
The spectroscopic techniques employed were UV-Visible, EPR studies and 
electrochemistr}' to give an insight into the mode and nature of binding [107-109], 
Electrochemistry has been employed more often to probe intercalation and electron 
transfer in DNA [110-112], The electrochemistry and UV/Vis/EPR spectro-
electrochemistry of Ir(phi)(bpy)(phen)^'^ reveal a reversible one electron, phi centered 
1 1 
reduction in aqueous solution, but a two-electron process to give a phi-lr(II) diradical 
when intercalated into DNA. 
Reaction of [Ru(III)(edta)(H20)]" with L' (L' = adenine, adenosine, cytosine, cytidine or 
thymine) and calf thymus DNA was studied by spectrophotometric, electrochemical and 
kinetic methods [113]. The E,/2 values for the Ru(fn)-Ru(n) couple for [Ru(nO(edta)L']' 
were in the range -0.28 to -0.15 versus saturated calomel electrode. Cyclic voltammetric 
potential E1/2 for [Ru(III)(edta)L']"-[Ru(lll)(edta)L']'^ redox couples are given in 
Table I. Based on literature survey [114], the probable nucleoside sites for transition-
metal ion binding in these complexes was assumed for adenine and adenosine to bind 
through N7 while cytosine and cytidine binds through N3 position. The positive shift in 
peak potentials observed in [Ru(IJI)(edta)L'J" complexes, L' = adenine or adenosine 
accounts for 7i-interaction through imidazole type N7 site (Figure 6) of purine bases. 
200 4 0 0 6 0 0 
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Figure 6. Spectra of aqueous solution of (a) [Ru(III)(edta)(H20)f and (b) 
[Ru(III)(edta)(H20)f + adenine in H2O; {inset, spectrum of 
[Ru(III)(edta) (adenine)] in the presence of adenine}, (c) spectrum 
of adenine in HjO. 
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Table 1. Spectral and electrochemical data for the reactions of [Ru(III)(edta)(H20)]' 
with L' in aqueous solution atpH 5.2,1 = 0.2 mol dm'^ (KCl). 
System* ).max/nm Ei/zA^ 
[Ru(III)(edta)(H20)]- 283 -0.28 
[Ru(III)(edta)(H20)]" + adenine 292 -0.12 
[Ru(III)(edta)(H20)]" + adenosine 295 -0.15 
[Ru(III)(edta)(H20)]- + cytosine 301 -0.27 
[Ru(III)(edta)(H20)]- + cytidine 304 -0.27 
[Ru(III)(edta)(H20)]' + thymine 301 -0.26 
*[Ru(III)] = 5 X 10"* mol d m \ [L] = 5 X 10'^ mol dm'^ 
which shifts some electron density from the metal to the ligand. Kinetics of 
[Ru(III)(edta)(H20)]' with L' were followed as an absorbance increase at 340 nm and in 
all cases except (adenine) absorbance-time traces were found to be single exponential. 
The rate of formation of [Ru(llI)(edta)L']" was found to be first order with respect to 
[Ru(III)(edta)(H20)]" concentration. The values of k^bs, increased linearly by increasing 
L' with significant intercept (Figure 7). The kinetic behavior observed for the reaction of 
[Ru(lII)(edta)(H20)]' with L' was interpreted by equation (1) and a rate expression was 
given by the equation (2). 
[Rii(III)(edta)(H20)]- . L' ^ " [Ru(III)(edta)LT . H2O (1) 
kobs = k,[L'] + k2 (2) 
The slopes and intercepts of the kobs. versus [L'] plots (Figure 7) gave the values of k\ and 
k2 respectively. 
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Figure 7 Plot of kobs versus [L'], L' = (a) adenine, (b) adenosine, (c) cytosine and (d) 
cytidine. 
Kinetics of the reaction of [Ru(III)(edta)(H20)]" with calf thymus DNA were studied at 
320 nm where an appreciable absorption change occurred. A typical kinetic trace under 
pseudo-first-order condition of excess DNA are depicted in Figure 8 which exhibit a 
single exponential feature as the traces did not change even at the highest time of stopped 
flow mstrument. The rate law derived for this reaction is 
ko,s = k ^ m A ] + k, (3) 
The results clearly support the binding of the complex to a single-strand calf thymus 
DNA via. adenine in a kinetically favored route. 
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Figure 8 Kinetic trace for the reaction of [Ru(III)(edta)(H20)]' with DNA The 
difference between experimental and fitted traces is given at the top of the 
figure 
Copper is a bio-essential element widely distributed in the biological systems such as 
cells and body fluids. Copper complexes have been extensively utilized in metal-
mediated DNA cleavage for the generation of activated oxygen species [115], 
Recent reports on copper(II) complexes containing organic moieties as photosensitizers 
and planar heterocyclic bases as DNA binders have shown that they efficiently cleave 
DNA on photoirradiation [116-118]. Photofrin-II^which is mixture of hemato porphyrm 
and its derivatives, has been extensively used as a drug for photodynamic therapy of lung 
and esophageal cancer activated by laser irradiation at 630 nm to generate cytotoxic 
singlet oxygen for cell necrosis [119,120] Copper(II) salicylaldoxime complex of formula 
(CuSAL) (Figure 9) was reported as an antitumour drug which induces topoisomerase II 
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Figure 9. Chemical structure ofCuSAL. 
(topo II), which is a nuclear enzyme crucial for resolving DNA knots in the chromosomes 
during replication, transcription and cell division. This complex induces topo II to form 
single strand nicks in DNA and poison its activity, which could be one of the possible 
mechanism for its anti-cancer activity [121], 
The interaction of copper(II/I) complexes of 2,9-dimethyl-I,10-phenanthroline with calf 
thymus DNA were investigated by Palaniandavar et al. [122] using absorption, circular 
dichroism and electrochemical techniques. As the 2,9-methyl substituents stabilize the 
copper(l) over the copper(II) state, these complexes display little nuclease activity [123] 
so that it was possible to focus on their noncovalent binding interaction with DNA. 
The observation of hypochromism and the novel hyperchromism in the absorption 
spectra of [Cu(I)(bcp)2]'^ [bcp = 2,9-dimethyl-4,7-diphenyl-l,10-phenanthroline], 
[Cu(I)(dmp)2]^ [dmp = 2,9-dimethyl-I,10-phenanthroline], and [Cu(I)(dbsmp)2]^' 
[dbsmp^" = 2,9-dimethyl-4,7-bis(sulfonatophenyl)-l,10-phenanthroline], respectively in 
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the presence of DNA suggested partial intercalation which was further authenticated by 
viscosity studies (Figure 10). 
-409 • oo cao 
Figure 10. Charge transfer spectra of [Cu(ll)(dbsmp)2]'^' in absence (-) and presence 
(—) oj increasing amounts of calf thymus DNA. 
Electrochemical bcha\ior of the [Cu(I)(bcp)2]^'^^ [Cu(I)(dmp)2] " and 
[Cu(II)(dbsmp)2]^"''^" complexes reveal the fairly reversible behavior of the Cu(II)/Cu(I) 
couple. On the addition of DNA, the dmp and bcp complexes experience negative shifts 
in Ei/2 and a decrease in AEp at lower scan rates. The ratio of cathodic to anodic peak 
currents, ipc/ipa (~1). For dpsmp complex, the ratio ipa/ipc was greater than unity as 
depicted in Figure 11. 
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Figure 11. Cyclic voltammograms of Cu(II)(dbsmp)2] in absence (—) and presence (—) 
of increasing amounts of calf thymus DNA. 
The ratio of the equilibrium constants, K2+/K4 for the binding of the copper(II) and 
copper(I) forms of complexes to DNA was estimated by this equation. 
Eb°'- Ef''' = 0.0591og(K+/K2.) 
Where Ef° and Eb° were the formal potentials of the Cu(Il)/Cu(I) couple in the free and 
bound species, respectively. It was observed that DNA-bound complexes, the K2^/K+ 
decreases in the order dmp > bcp > dpsmp. 
Some reports on the interaction of cobalt(II) and copper(ll) complexes with calf thymus 
DNA employing UV-Visible spectroscopy and cyclic voltammetry have been published 
by our research group [124-129] 
The complexes on interaction with calf thymus DNA, exhibit shifts in wavelength along 
with increase (hyperchromism) or decrease (hypochromism) in absorbance. Such small 
changes in Amax have also been observed upon interaction of calf thymus DNA with other 
copper complexes [130,131]. Strong hypochromism and red shifts are usually attributed 
for intercalation [132], while hyperchromism results from the damage of DNA double 
helix structure [133]. This effect may thus interfere with the template function of DNA 
and inhibit the replication and synthesis of DNA which accounts for the antitumor 
activity of the compounds. 
The cyclic voltammograms of the copper complexes in absence and in presence of calf 
thymus DNA exhibit a shift in both electrode potentials Epc, Epa and E1/2 values. The ratio 
of ipa/ipc for DNA bound complex decreases suggesting the calf thymus DNA is bound 
strongly to the complexes. Further, the addition of DNA causes all the peak currents to 
diminish considerably which is due to the diffusion of the equilibrium mixture of free and 
DNA-bound metal complex to the electrode surface. A strong binding to DNA would 
lead to a decrease in current, due to diffusion of the Cu-complex-DNA adduct formed. 
However, diffusion of the free copper complex in a solution of increased viscosity or 
blockage of the electrode surface by an adsorbed layer of DNA that could possibly form 
at the electrode surface also contributes to the decrease in current [134]. This is revealed 
by the decrease in current (17%) for the redox-active control K4[Fe(CN)6]. Also the 
current from a bound, electrochemical ly reversible label may have interference from any 
freely diffusing species. 
Metal ions binding to nucleic acid has been studied by several techniques including 
conductimetry [135,136], UV-Vis spectroscopy [137-142], equilibrium dialysis [143,144J 
and X-ray crystallography [145-147]. 
However, all these techniques present considerable experimental difficulties or 
limitations. For example, conductivity experiments are not suitable as the contribution of 
the partially complexed macromolecules to the conductivity is neither negligible nor 
constant. In X-ray crystallography studies, it has found that, in many cases the 
conformation of nucleic acids in crystals and in solution are not identical because there 
are more intermolecular interactions in a solid phase than in dilute solution [148]. The 
UV-Vis spectroscopy is employed generally, but many metal complexes show small 
changes in molar absorptivity on binding to DNA. 
a 
The electrochemical methods (cyclic voltammetry and pulse voltammetry) has several 
advantages over other methods, it can complement spectroscopic techniques like UV-Vis 
and can be employed to determine the strength of binding of the complex and the size of 
binding site (i.e., number of base pairs) by studying the vohammetry of the complex in 
the absence and presence of DNA. The shifts in standard potential caused by the 
interaction of DNA provide surmount information regarding the binding of the complex 
with DNA [149]. 
Binding of zinc to lambda phase DNA was investigated by different pulse and cyclic 
voltammetry [150]. The cyclic voltammogram of zinc(II) with different concentrations of 
lambda phase DNA are shown in Figure 12.curve-1 represents the oxidation of zinc 
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Figure 12. Cyclic voltammograms ofZn(II), curve 1 in the absence of lambda phase 
DNA, and curves 2, 3, 4 in the presence of increasing concentration of lambda 
phage. 
while curve no. 2,3 and 4 show the decrease of the oxidation current of zinc during 
incremental addition of lambda phase DNA. The resulting changes in this current again 
demonstrate interaction between zinc(II) and lambda phage DNA. 
The macrocyclic complexes CUL'(C104)2. CuL^Cb and CuL^Cb where, L' = 1.4,8,11-
tetraazacyclotetradecane, \ } = 3,10-bis-phenethyl-l,3,5,8,10,12-hexaazacyclotetradecane 
and L^ = 3,10-bis-propyi-l,4,5,8.I0,12-hexazacyclotetradecane were reacted with DNA 
in different binding modes and exhibited effective nuclease activities (I'igure 13). Their 
different structural features on the side chains may result in different DNA binding 
interactions by intercalation, hydrogen bonding, van der Waals forces, hydrophobic 
interaction or coordination between cupric ion in the complex and base nitrogen in DNA 
[151], Such ligand modification provide an opportunity to obtain structural insight into 
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Figure 13. Chemical structures of the macrocyclic copper(II) complexes. 
the binding event. The absorption spectra of the macrocyclic complexes in the absence 
and the presence of calf thymus DNA are shown in Figure 14. It have been observed that 
all the copper(II) complexes exhibit an intense absorption band in UV region at 250 nm 
which is attributed to an n - 7i* or 7i - ti* transition. 
With increasing concentration of calf thymus DNA. the absorption bands of the 
complexes were affected, resuhing in the obvious tendency of hyperchromism or 
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Figure 14. Absorption spectra of(l) CuL'(004)2. (2) CuL^Chand (3) CuL^Ch in the 
absence (—) and in the presence (—) of increasing amount of DNA. 
hypochromism and a slight red shift. An electronic interaction between copper(II) 
coordination compounds and DNA was observed through the data of hyperchromism or 
hypochromism and shifts in the absorbance maxima of the copper(II) complexes. 
(Table 2). CuL^Ch complex shows hypochromism indicative of intercalation mode [152] 
while CuL'(C104)2, and CuL^Cli complexes do not contain any fused aromatic ring 
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Table 2 Effects of CTDNA on the absorbance bands and binding constants of 
CuL'(C104)2 , CuL^Cb andCuVCh 
,x /nm 
Compound Free Bound AX/nm H ' ( % ) K t M 
CUL'(CI04)2 253.4 254.1 0.7 +3.9 1.3 X 1 0 ' 
CuL^Cl2 252.4 252.4 0 -17.6 2.1 X 10'' 
237.6 237.4 -0.2 -15.0 
195.8 204.5 8.7 -9.0 
CuL^Cb 250.6 252.6 2.0 + 11.6 4.6 X 10^ 
231.6 231.6 0 -0.1 
^ +, hyperchromism; hypochromism. 
to facilitate intercalation. Thus classical intercalative interaction would be impossible. 
The "hyperchromism" of CUL'(C104)2, and CuL^Ch complexes caused by addition of 
calf thymus DNA implies clearly that the binding mode is probably hydrophobic 
interaction between the methyl groups in the complexes and DNA polyanion. Such 
hyperchromic effect has also been observed for the soret bands of certain porphyrins 
when interacted with DNA [153] and for a copper(II) complex with a ligand bearing -NH 
and -OH groups [154]. DNA possesses several hydrogen bonding sites which are 
accessible both in the minor and major grooves, while the two complexes contain four 
coordinated amine - N H groups in the macrocycle which could form hydrogen bonding 
with base pairs in DNA. 
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Nickel compounds have been found to inhibit DNA replication and transcription 
processes in vitro and in vivo and are known to cause non-random assault on DNA of 
cultured mammalian cells, resulting in chromosomal aberrations [155,156]. However, 
nickel compounds are speculated to be carcinogenic both in humans [157] and 
experimental animals [158J. Our interest in nickel(ir) compounds was only for 'H and ' 'C 
NMR spectroscopic point of view, although recently the effect on DNA and the 
antibacterial activity of a series of high nuclearity nickel compounds with three, four and 
five metal atoms were examined [159]. 
Organocobalt porphyrins derivatives of tetracationic water-soluble porphyrin 
[CHsCoCPor)]^^ cations afforded [CH3CoTMpyP(4)]^'^ and [CHsCoTMAP]"^ where 
[TMpyP(4)]''^and [TMAP]^^ are the coordinated, NH-deprotonated forms of meso-tetrakis 
(N-methyl-4-pyridiniumyl) porphyrin and meso-tetrakis (N,N,N-trimethylaniliniumyl) 
porphyrin, respectively [160].The binding of two new [CH3Co(Por)]'''^ cations to DNA 
and to synthetic DNA polymers [poly(dA-dT)]2 and [poly(dG-dC)]2 was studied, 
literature [161,162] supports the changes in visible and CD spectra in the soret region can 
be used to assess DNA binding. A large hypochromicity of the soret bands of these 
cations observed upon binding to DNA indicates a high degree of stacking. The 
[CO(I1I)(NH3)5CH3]^'' cation (Figure 15) is the simplest organocobalt(III) compound with 
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one coordinated cation atom and five coordinated nitrogen atoms . Tlie trans-labilising 
methyl group promotes facile ammine ligand exchange substitution with simple ligands 
such as H2O, NO2', CN" and 1,2 ethylenediamine in [Co(III)(NH3)5CH3]^^ and most of 
these have been reported earlier [163,164]. 
Similarly, a series of inert cationic cobalt(III)-sar (sar-sarcophagine = 3,6,10,13,16,19-
hexaazabicyclo [6.6.6] icosane) cage complexes covalently linked to polycyclic rings 
such as anthracene or phenanthrene were explored for their DNA binding ability and 
cleaving properties [165]. The hydrophobic polycyclic aromatic cobalt(III) sar cages are 
effectively solubilised in water and have the prospect of intercalating with DNA. The 
complexes being cationic associate with negatively charged phosphodiester backbone of 
DNA. 
The interaction of DNA is metal-dependent [166], To evaluate this effect, a series of 
metal complexes, copper(II), nickel(ll), cobalt(II) and manganese(II) of 2,9-bis 
(2-hydroxyphenyl)-l,10-phenanthroline compounds were studied and the effects of these 
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metals on the temperature-dependent helix-to-coil transition of DNA was measured. The 
results show that highest stabilization was observed with the cobalt complex (Figure 16). 
Figure 16, 
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The DNA cleaving studies with plasmid DNA reveal that cobalt complex acts as a potent 
DNA cleaves in the presence of reducing agent, whereas surprisingly under identical 
conditions copper complex was totally inactive. Cleavage of DNA b\ salen complexes of 
nickel and manganese could be achieved in the presence of oxygen donor compounds 
such as (KHSO5) potassium monoperoxysulphate and (MMPP) magnesium monopcroxy-
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phthalic acid and there was absolutely no cleavage with uncomplexed nickel and 
manganese metals or with KHSO5 alone. 
The geometry of the designed ligand was apparently not well suited for complexation 
with copper and nickel but was adequate for complex formation with cobalt and 
manganese. Further, manganese complex produces oxygen radicals that are responsible 
for the efficient cleavage of DNA under reducing conditions. 
There is an increasing interest in the chemistry of organotin compounds and their 
studies with different biomolecules e.g. carbohydrates, [167,168] nucleic acid derivatives, 
[169,170] amino acids [171] and peptides [172]. Several reports have shown the versatile 
coordination chemical behavior of organotin cation towards ligand molecules containing 
different types of donor sets e.g. (-0), [173] (-0, -N), [174-176] or (-N, -S) [177] 
including both solid state and solution studies. Recently, two diorganotin(IV) complexes 
of the general formula R2Sn[Ph(0)C=CH-C(Me)=N-N=C(0)Ph] (R = Ph, Me) have been 
synthesized from the more flexible hydrazone ligand (4-phenyl-2,4-
butanedionebenzoylhydrazone) [178] and were structurally characterized in both solid 
and solution state by X-ray crystallography and NMR [179,180]. The structural 
comparison in both states helps to elucidate the structure of new organotin(IV) complexes 
using NMR spectral results where X-ray data are not available. The central tin atom of 
both complexes adopts a distorted trigonal bipyramidal coordination with two ligand 
oxygen atoms in axial position, the nitrogen atom of the ligand and two organic groups 
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on tin occupying equatorial sites. The 5("^Sn) values for the complexes are -151.5 and 
-146.8 ppm, respectively indicating penta-coordinated tin centers (Figure 17). 
Figure 17. Constitution of compounds Ph2Sn[Ph(0)C=CH-C(Me)^N-N=C(0)Ph] and 
Me2Sn[Ph(0)C=CH-C(Me) =N-N=C(0)Ph]. 
To study the versatile bonding modes of organotin(IV) complexes [181] especially 
organotin(IV) derivatives from heterocyclic thionates [182,183], a series of organotin(IV) 
complexes with 2,5-dimercapto-l,3,4-thiodiazole of the type (RnSnClni)2 (dmt) 
(m = 0, n = 3, R = Ph, PhCHi, n-Bu; m =1, n = 2, R = Ph) and [R2Sn(dmt).L]n 
(L = O.SCeHe, R = CH3; L = 0, n = 5, R = n-Bu) were synthesized and characterized by 
elemental analysis, IR, 'H and '^C NMR spectra [184]. 
The tin and organotin compounds exhibit a wide range of potential applications, 
including cmtitumor activity, based on their structural and biological properties and they 
have been well documented in the literature [185-189]. It have been observed that 
diorganotin(IV) derivatives, and mainly those of dialkyltin(IV) appear to be most active 
[190-193] against different tumor cells and their structures in the solid state are well 
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characterized [194], Evidence for the coordination of dimethyltin(lV) cation to phosphate 
groups of DNA or DNA fragments has been found both in solution [195] and in solid 
state [196]. 
Organotin compounds have shown more antineoplastic effect against P388 leukemia in 
mice than any other class of compounds [197] and have been associated with the 
activation of nuclear endonucleases associated with apoptotic DNA cleavage [198,199]. 
Mouse thymocytes treated with triphenyltin acetate in cell culture exhibit chromatin 
condensation, cell membrane fragmentation, and formation of membrane-bound 
apoptotic bodies suggestive of apoptosis [200], However, they have not received as much 
attention as the platinum compounds. In a recent study, the effect of tin antitumor agent, 
on the apoptotic pathway of human cervical carcinoma cells (HeLa) was compared and it 
was found that TPT-benzimidazolethiol is more effective against a human cervical cancer 
cell line [201]. During dose-dependent experiments that a low dose of TPT 
benzimidazolethiol (2 i^g/ml) could efficiently kill HeLa cells at a rate of almost 90%; in 
contrast to 16 ^g/ml of cisplatin at the same concentration killed fever then 10% of Hela 
cells, thus TPT-benzimidazolethiol acts as a potent inducer of apoptosis in HeLa cells 
[202]. 
With the exception of cisplatin, there is relatively little mechanistic information on 
platinum and nonplatinum anticancer drug function but it is clear that the metal ions play 
a vital role in drug therapy. 
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Present work 
Many first-row transition-metal ions are of key importance in biology, especially iron, 
copper and zinc. The selection of the "correct" metal ion is crucial for metallo-
biomolecules interaction as it plays a direct role in oxidation reduction reactions, while 
the size and charge of the metal ion may be influential aspects in governing the 
conformational changes in biomolecules. For instance, metal ions that preferentially bind 
to nucleobases may cause more dramatic effects on DNA conformation than those 
binding to the phosphate and sugar backbone. 
Metals are known to have preferences for certain ligands and ligand design plays a major 
role in drug designing, diagnostic agents and for bioinorganic model complexes 
[203,204], Some of the such ligands are given in Figure 18 [205], Furthermore, ligands 
bicinchonic acid COOH CI 
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Figure 18. Some examples of designed ligands in medicinal chemistry. 
bearing -NH2 group [206], -SO2NH [207], derivatives of tlie benzimidazole [208] and 
macrocyclic moieties [209] are quite promising in methods for the inhibition cell 
proliferation, for treating viral infections, cancer or neoplastic disease and for modulating 
apoptosis. Special attention has been focused on the design of the molecular structure of 
the compounds. The ligands which are capable of coordinating with the metal ions are 
biological significant robust molecules viz. sulphapyridine, iminodiacetic acid, boron 
derivatives of aminobenzothiazole and benzimidazolethiol derivatives and each of them 
have their own biological significance. 
The importance of the sulphonamide unit in medicinal chemistry cannot be overstated 
[210,211], Sulphonamides constitute the largest and best known class of bacteriostatic 
agents [210,211] and has shown to be a transition state mimick of peptide hydrolysis, and 
in particular the critical motif for potent, irreversible inhibitors of cysteine proteases 
[215,216]. These drugs have found application in standard treatments e.g. sulphasalazine 
(salazopyrin). where mesalazine is joined to a sulphapyridine, was used to treat ulcerative 
colitis and acts as an anti-inflammatory drug in the treatment of rheumatic fever and 
rheumatoid arthritis [217-219], Similarly, dermatitis herpetiformis, a skin disorder, was 
treated with sulphapyridine and sulphones [220], The structure of sulphapyridine is 
shown in Figure 19, From spectroscopic studies, it is evident that the sulpha drugs behave 
as bidentate ligands through the N.suiphamido and the N.heterocydic atoms 
[221], Metal complexes of these sulphadrugs have been extensively studied [222-224], 
H i N H l j ) - S 0 2 - N H -
N 
Figure 19. Structure of sulphapyridine 
Sulphapyridine, a biologically significant member of the sulphonamide class of drugs, 
has been reacted with diethyl oxalate to yield a new drug derivative 
1,2-bis(sulphapyridyl)oxamide [L] which can act as a promising/potential anti HIV drug. 
There are a number of reports on oxalate bridged transition metal complexes [225-227] 
and pyridine amide complexes [228,229], however, there is scarcity of literature on 
metal-based drugs of sulphapyridine oxalate derivatives. To explore the coordination 
sites, new metal complexes of 1,2-bis(sulphapyridyl)oxamide have been synthesized with 
iron(III), cobalt(II), copper(II) and zinc(II). The binding of the cobalt(II) complex with 
bovine milk casein (BMC) has been studied by spectrophotometry in phosphate buffer 
at different pH's. A buffer has a strong and well-characterized interaction with the metal 
complex and helps in suppressing metal ion hydrolysis and precipitation, thus allowing 
high affinity metal binding sites on biological macromolecules. 
In another set of experiments 2,2'-(oxalydimino)bis(diacetic acid) ligand was synthesized 
by bridging 2 moles of iminodiacetic acid through oxamide linkage. Oxamides are well-
known to be versatile ligands which can chelate as well as bridge metal ions to build 
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polynuclear and low-dimensional molecules [230]. One of the most outstanding 
characteristic feature of these ligands is the transformation of cis-trans conformation, 
which makes it possible to design molecular materials with extended structure and 
desired properties. On one hand, the bidentate chelating character of the mononuclear 
metal compounds of cis-oxamidates makes them good precursors to build bi [231], tri 
[232] and even penta-nuclear [233] homo- and hetero-metallic molecular entities. On the 
other hand, the bis-terdentate character of trans-oxamidates favours the formation of 
trans-oxamidato-bridged binuclear units with unsaturated coordinated sites, which may 
act as the building blocks to be further linked by a second bridging group to construct 
extended systems [234], 
Protein metal complex interaction has been investigated due to its application in 
pharmaceutical industry as specific target drugs. Human serum albumin (HSA) is a 
principal binding protein in blood plasma for a large number of drugs of great interest to 
study the HSA-metal complex interactions [235], The binding process controls the 
concentration of the free or bioactive, drug and hence affects the drug's 
pharmacokinetics, storage, toxicity, transportability to the tissues and through cell 
membranes [236]. A series of metal complexes (Co(n), Ni(II) and Cu(II)) of triethylene 
tetraamine and 2,2'-(oxalydimino) bis(diacetic acid) ligand have been synthesized and 
characterized adequately by various physicochemical methods. The interaction of HSA 
with the Cu(II) complex has been studied spectrophotometrically and also by cyclic 
voltammetry, to ascertain the binding mode of Cu(ll) complex with HSA. 
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Heterobimetallic complexes have become subject of frontier research, owing to their 
diverse application in homogeneous catalytic processes, in enzyme model systems for 
metalloproteins, viz. superoxide dismutase, oxidase, peptidases and magnetic exchange 
between the paramagnetic centers [237-239]. Bioinorganic chemists have made 
considerable efforts to study the active sites involving more than one metal center due to 
their diversity in biology [240-242], 
The newly synthesized ligand, dihydro OO'bis(salicylidene) 2,2' aminobenzothiazolyl 
borate was derived from the reaction of Schiff base of 2-aminobenzothiazol and 
salicylaldehyde with KBH4. Cu(Il) and Zn(II) complexes of dihydro 
00'bis(sa!icylidene) 2,2' aminobenzothiazolyl borate were synthesised and further 
metallated with dimethyltindichloride to yield bimetallic complexes. The kinetic and 
electrochemical behavior of the representative complex (C32H3gN4S207BCuSn2Cl5) 
towards guanine, adenine and calf thymus DNA was studied to understand the 
mechanistic approach of binding to a target molecule. These studies were carried out 
mainly due to a few reasons- the binding ability of the complex is multifold due to the 
presence of two metal ions which selectively bind to the target site viz. copper, a 
transition metal ion has possible advantages; it can expand its coordination number, 
change in oxidation state and alteration in ligand affinity and substitution kinetics is 
possible. Further, it prefers binding to N7 of guanine or adenine to a lesser extent of the 
nucleotide bases while tin(IV) cation binds to the phosphate group of the DNA 
backbone. Evidence for the coordination of dialkyl tin(IV) cation to phosphate groups of 
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DNA or DNA fragments has been found both in solution [243] and in the solid state 
[244]. Moreover, the affinity of tin(IV) with dinegative phosphate group is strong 
because of its hard Lewis acidic property [245], Alkyl tin compounds were reported to be 
effective against some types of cancers, such as P-338 leukemia [246] and such alkyl tin 
compounds containing the borate ligands have further advantage of exhibiting therapeutic 
success by healing the damaged cells. 
There is considerable interest in the pharmacology of heterocyclic ligands and their metal 
chelates [247]. In general, nitrogen and sulfijr containing organic compounds and their 
metal complexes display a wide range of biological activity [249-252], as antitumor, 
antibacterial, antifungal and antiviral agents. 
Novel substituted benzimidazole derivatives are stated to be inhibitors of cyclin-
dependent kinase and are useful for inhibiting cell proliferation, in for the treatment of 
cancer. The activity of the compounds was determined by cyclin-dependent kinase 
(CDK) 4/cyclin D1 and CDK2/cyclin E flashplate assays [253]. Bis-benzimidazoles have 
also potent activity against a number of microorganisms bacterial infections, antiamoebic 
agents including those related to anti-HIV (AIDS) [254]. To design highly effacions 
drugs (with reduced toxicity and low dosage), it is necessary to label the specific target 
which could be a DNA molecule in a cell, tissue or an entire organ of the living system. 
Thus the potential drugs should not only be DNA targeted but should exhibit specific 
biological activity in particular, nucleotide sequence in DNA. 
The ligand L [C16H10O2N4S2] and its complexes with Ni(n) and Cu(II) chloride were 
synthesized and characterized by elemental analyses, i.r., n.m.r., u.v./vis spectroscopy 
and molar conductance measurements. Binding studies of the DNA-metal complex 
[C2oH22N8S2Cu].Cl2 wcre carried out spectrophotometrically, cyclic voltammetry and 
viscometry. Kinetic studies of the complex [C2oH22NgS2Cu].Cl2 trisbuffer/DMSO 
solution at 260 nm (X^ a^x of DNA) under pseudo first order conditions exhibits strong 
binding of the complex which is ascertain by rate constant, k^bs, obtained by the linear 
least squares method. The results obtained b>' kinetics are further authenticated by cyclic 
voltammetry. The redox potential values shift considerabh on interaction with calf 
thymus DNA. These results are well in agreement with viscosity measurements 
indicating the interaction of the complex [C2oH22N8S2Cu].Cl2 with calf thymus DNA 
CHAPTER II 
EXPERIMENTAL 
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CHAPTER II 
EXPERIMENTAL METHODS 
The following techniques were employed to characterize the complexes 
1. Infrared spectroscopy 
2. Ultra-violet and visible spectroscopy 
3. Nuclear magnetic resonance spectroscopy 
4. Electron paramagnetic resonance spectroscopy 
5. Molar conductance measurements 
6. Cyclic voltammetry 
7. Kinetic studies 
8. Viscometry 
9. Biological activity 
Infrared spectroscopy 
The infrared spectroscopy is a useful technique to characterize a compound. It results 
from transition between vibrational and rotational energy levels. I.r. region of the 
electromagnetic spectrum covers a wide range of wavelength from 200 to 
4000 cm"'. It has been found that in i.r. absorption, some of the vibrational frequencies 
are associated with specific groups of atoms and are the same irrespective of the 
molecules in which this group is present. These are called characteristic frequencies [255] 
and their constancy results from the constancy of bond force constants from molecule to 
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consists of characteristic group frequencies which makes i.r. spectroscopy, an unique and 
powerful tool in structural analysis. 
Ultraviolet and visible spectroscopy 
When a molecule absorbs radiation, its energy is increased. This increased energy is 
equa] to the energy of the photon expressed by the relation 
E = hv 
E = he / \ 
where h is Planck's constant, v is the frequency, X is the wavelength of the radiation and 
c is the velocity of light. Most of the compounds absorb light in the spectral region 
between 200 and 1000 nm. These transitions correspond to the excitation of electrons of 
the molecules from ground state to higher electronic states. In a transition metal, all the 
f ive 'd" orbitals viz. d^j, dy ,^ d^ ,^ d / and d^ .^^ ^ are degenerate. However, in coordination 
compounds due to the presence of ligands, this degeneracy is destroyed and d orbital 
split into two groups tjg (d^^, d,? and dx7) and Cg (d?' and d^ .^^ ^) in an octahedral complex 
and t and e in a tetrahedral complcx. The set of tjg orbitals goes below the original level 
of degenerate orbitals in octahedral complexes and the case is reversed in tetrahedral 
complexes (Figure 20). At energy higher than the ligand-field absorption bands, 
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Figure 20(b). Ligand-fieldsplitting of tetrahedral complex. 
we commonly observe one or more very intense bands that go off scale unless log e is 
plotted. These normally are charge transfer bands, corresponding to electron transfer 
processes that might be ligand — • metal (I .—• M) or metal — • ligand ( M — • L). 
M — • L transitions occur for metal-ion complexes that have filled, or nearly filled, tig 
orbitals with ligands that have low-lying empty orbitals. These empty orbitals are ligand 
71* orbitals in complexes such as those of pyridine, bipyridine, 1,10-phenanthroline, CN", 
CO and NO. Figure 21 shows overlap of a tig metal orbital and n* of CO. 
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Figure 21. Metal-carbon double bonding. 
The L —> M charge-transfer (C-T) spectra have been studied more thoroughly. The 
intense bands are for LaPorte-allowed transitions commonly of the (ligand) p —• d 
(metal) type. The ionization energy for the ligand (or its ease of oxidation) as well as the 
oxidation state and electron configuration of the metal (or its ease of reduction) determine 
the energy of the transition. No net oxidation-reduction usually occurs, because of the 
short lifetime of the excited state [256]. 
Nuclear magnetic resonance spectroscopy 
The nuclei of certain isotopes possess a mechanical spin or angular momentum. The 
n.m.r. spectroscopy is concerned with nuclei having spin quantum number I = 1/2, 
example of which include 'H, '^C, ^'P and '^F. 
For a nucleus with I = 1/2, there are two values for the nuclear spin angular momentum 
quantum number mj = ±1/2 which are degenerate in the absence of a magnetic field. 
However, in the presence of the magnetic field, this degeneracy is destroyed such that the 
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positive value of mi corresponds to the lower energy state and negative value to higher 
energy state separated by AE. 
In a n. m. r. experiment, one applies strong homogeneous magnetic field causing the 
nuclei to precess. Radiation of energy comparable to AE is then imposed with radio 
frequency transmitter is equal to precision or Larmor frequency and the two are said to be 
in resonance. The energy can be transferred from the source to the sample. The n. m. r. 
signal is obtained when a nucleus is excited from low energy to high energy state. 
Electron spin resonance spectroscopy 
E.P.R spectroscopy [257] is the branch of absorption spectroscopy in which radiation 
having frequency in the microwave region is absorbed by paramagnetic energy levels of 
electrons with unpaired spins. The magnetic energy splitting is done by applying a static 
magnetic field. For an electron of spin S = 1/2, the spin angular momentum quantum 
number will have values of ms = +1/2. In absence of magnetic field, the two values of ms 
i.e. +1/2 and -1/2 will give rise to a doubly degenerate spin energy state. If a magnetic 
field is applied, this degeneracy is lifted and leads to the non-degenerate energy levels. 
The low energy level will have the spin magnetic moment aligned with the field and 
correspond to the quantum number ms = -1/2. On the other hand, the high energy state 
will have the spin magnetic moment opposed to the field and correspond to the quantum 
number m. = +1/2. 
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Conductance measurements 
The conductivity measurements is one of the simplest and easily available techniques 
used to study the nature of complexes. It gives direct information regarding whether a 
given compound is ionic or covalent. For this purpose, the measurement of molar 
conductance (Am), which is related to the conductance value in the following manner is 
made. 
cell constant x conductance 
Am = 
concentration of solute expressed in mol cm"^ 
Conventionally, solutions of 10"^  M strength are used for the conductance measurements. 
Molar conductance values of different types of electrolytes in a few solvents are given as, 
1:1 electrolyte has a value of 80-115 ohm"' cm^ mol"' in methanol, 50-75 ohm"' cm^ mol"' 
in dimethylformamide 78-80, 65-90 ohm"' cm^ mol"' dimethylsulphoxide and 35-45 ohm"' 
cm^ mol"' in ethanol [258,259]. Similarly a solution of 2:1 electrol>tc has a value of 
160-220 ohm"' cm^ mol"' in methanol, 130-170 ohm"' cm^ mol"' in dimethylformamide 
and 70-90 ohm"' cm^ mol"' in ethanol. 
Cyclic voltammetry 
Cyclic voltammetry involves the measurement of current-voltage curves under diffusion 
controlled, mass transfer conditions at a stationary electrode, utilizing symmetrical 
triangular scan rates ranging from a few millivolts per second to hundred volts per 
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second. The triangle returns at the same speed and permits the display of a complete 
polarogram with cathodic (reduction) and anodic (oxidation) waveforms one above the 
other. Two seconds or less is required to record a complete polarogram [260]. 
Consider the reaction 
O + ne • R (i) 
Assuming semi-infmite linear diffusion and a solution containing initially only species 0 . 
With the electron held at a potential Ei where no electrode, reaction occur. The potential is 
swept linearly at v v/sec so that the potential at any time is 
E(t) = E , - v t 
or Epeak = Ei/2- 0.0285 
The rate of electron transfer is so rapid at the electrode surface that species 0 and R 
immediately adjust to the ratio according to the Nemst equation which is as follows, 
pt 
Co(0,t)= Co*-[nFA(7iDo) 'Y dx (ii) 
\y o 
i = nFACo*(7iDoa)'^^ x (CT t) (iii) 
Redox (electron-transfer) reactions of metal complexes can be investigated by cyclic 
voltammograms. An electrode is immersed in a solution of the complex and voltage is 
swept while current flow is monitored. No current flows until oxidation or reduction 
occurs. After the voltage is swept over a set range in one direction, the direction is 
reversed and swept back to the original potential. The cycle may be repeated as often as 
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desired Figure 22 shows tlie cyclic voltammograms (CV) for a reversible one-electron 
redox reaction such as, 
CpFe(CO)LMe • CpFe(CO)LMe^ + e" 
Sweeping the potential in an increasing direction oxidize the complex as the anodic 
current ia flows; reversible reduction of CpFe(CO)LMe"^ generates cathodic current ic on 
the reverse sweep. The magnitude of the current is proportional to the concentration of 
the species being oxidized or reduced. 
The measured parameters of interest on these cyclic voltammograms are ipg/ipc the ratio of 
peak currents and Epa - Epc the separation of peak potentials. For a Nernstian wave with 
stable product, the ratio ipa/ipc = 1 regardless of scan rate, E^ and diffusion coefficient, 
when ip.i is measured from the decaying current as a base line. The difference between Epa 
and Epc (AEp) is a useful diagnostic test of a Nernstian reaction. Although AEp is slightly a 
function of Ex. it is always close to 2.3RT/ nF. 
Figure 22. (a) Cyclic potential sweep (b) Resulting cyclic voitammogram 
45 
The technique yields information about reaction reversibilities and also offers a rapid 
means of analysis for suitable systems. The method is particularly valuable to study 
metallo-intercalation and interaction of metal ions to DNA as it provides a useful 
compliment to other methods of investigation, such as UV/Vis spectroscopy. Cyclic 
voltammetric measurements were accomplished with CH instrument electrochemical 
analyzer. Supporting electrolyte for all experiments was 0.4 M KNO3. A three electrode 
configuration was used, comprising of a platinum disk as working electrode, platinum 
wire counter electrode and Ag/AgCI as reference electrode. All solutions were 
deoxygenated via. purging with N2 at room temperature. 
Kinetic studies 
In a closed constant volume system, the rate of a chemical reaction is defined as the rate 
of change with time of the concentration of any of the reactants and products. The 
concentration can be expressed in any units of quantity per unit volume e.g. moles per 
liter, moles per cubic centimeter. The rate will be defined as positive quantity regardless 
of the component whose concentration change is measured. 
Consider the general chemical reaction 
aA + bB • cC + dD 
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The rate can be expressed as 
zdA , ^ , or M 
dt dt dt dt 
where A, B, C and D designate the concentration in arbitrary units. 
The rate of a chemical reaction is not measured directly instead the concentration of one 
of the reactants or products is determined as a function of time. A common procedure for 
determining the reaction order is to compare the experimental results with integrated rate 
equations for reactions of different orders. For a first order rate equation, integrating by 
separate variables using integration limits such that at t = 0, c = CQ and at t = t, c = c. 
[261]. 
-dc/dt = kc 
o r I n (CQ/C) = k t 
If the reaction is first order, a plot of In c or log c versus time should give a straight line 
with a slope o f - k or -k/2.303 respectively. The dependent variable chosen is the decrease 
in concentration of reactant. If this variable is designated as x and CQ is the initial 
concentration, 
dx/dt = k(co-x) 
lnco/(co-x) = kt 
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If however, the conditions for a given reaction are such that one or more of concentration 
factors are constant or nearly constant during a reaction, these factors are included in the 
constant k. In this case, the reaction is said to be of pseudo-nth order or kinetically 
nth order where n is the sum of the exponents of those concentration factors which 
time 
Figure 23. 
alter the reaction [262]. This situation is true for catalytic reactions where the 
concentration of catalysts remains constant throughout the reaction, if one reactant is in 
large excess over another so that during the reaction there is only a small percentage 
change in the concentration of the former reactant. 
All kinetic experiments including interaction of protein (BMOHAS) (where, BMC = bovine 
milk casein and HSA = human serum albumin), with the complexes were studied at X a^x 
of protein (BMC/USA) (278 nm) under pseudo-first-order conditions using a systronic 119 
spectrophotometer, cintra 5 UV/Vis spectrometer and Ocean optics spectrophotometer 
USB-2000. The absorbance changes with varying concentrations of protein (BMC/HSA) in 
phosphate buffer solution were recorded under fixed concentration of the complexes at 
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different time intervals. Pseudo-first-order rate constants kobs, were obtained by the linear 
least squares regression method. 
In another set of kinetic experiments involving interaction of the complex with guanine, 
adenine and calf thymus DNA were conducted in buffer (9.2 pH), doubly distilled water 
and tris-HCl buffer (7.5 pH), respectively. The progress of the reaction was monitored by 
measuring the changes in absorbance at 269 nm (complex + guanine), 260 nm (adenine) 
and 260 nm (calf thymus DNA), respectively. Pseudo-first-order rale constants k^ bs were 
determined from the slope of straight line. 
Calf thymus DNA was obtained from Sigma. The stock solution of calf thymus DNA was 
prepared by dissolving it in 10 mM tris(hydroxymethyl)aminomethane hydrochloride 
(tris-HCl) buffer at pH 7.5 and dialyzing exhaustively against the same buffer for 48 h. 
The solution gave a ratio of » 1 . 8 at A260/A280, indicating that calf thymus DNA was free 
from protein [263]. The concentration of calf thymus DNA was determined 
spectrophotometrically by monitoring the u.v. absorbance at 260 nm using I260 = 6600 
cm"'. The stock solution was stored at -20 °C. 
Viscosity Measurements 
Viscosity measurements were carried out using Ostwald's viscometer at 29±0.01°C. Flow 
time was measured with a digital stop-watch. Each sample was measured three times and 
an average flow time was calculated. Data were presented as (T|/T] 0) versus binding ratio 
([Cu]/[DNA]), where t] is a viscosity of DNA in the presence of complex and r|o 
is the viscosity of DNA alone. Viscosity values were calculated from the 
49 
observed flow time of DNA containing solution (t >100s) corrected for the flow time of 
buffer alone (to), T) = t- to 
Biological Activity 
Antibacterial Activity 
The antibacterial activity of the test compounds, mercaptobenzimidazole, 
[C16H10O2N4S2], [Cu(en)2].Cl2 and [C2oH22NgS2NgCuJCl2 were screened against bacteria 
(E. coli and S. aureus) by the well diffusion method using standard agar as the medium 
[264], Sensitivity plates were inoculated with bacteria (E. coli and S. aureus) and the well 
was loaded with test compounds solution using a micropipette. The incubation was done 
for 24h. at 37°C. During this period the test solution diffused zones of inhibition were 
recorded using vernier callipers. The radius of the zone is the measure of antibacterial 
activity. To evaluate the effect of concentration on antibacterial activity, four different 
concentrations (10, 20, 30 and 40 mg/mL) of the test compounds were screened against 
E. coli and S. aureus in DMSO by employing the same procedure. 
Antifungal Activity 
Antifungal activity of the test compounds were evaluated using the Sabouroud dextrose 
agar diffusion method. Weils were made (8 mm diameter) with a sterile cork borer. To 
these wells of the test compounds were added and the plates were allowed to cool for an 
hour to facilitate the difflision. The plates were then incubated at 37° C for 48h. At the 
end of the incubation period, the diameter of the zone of inhibition around the wells was 
measured. 
CHAPTER III 
Synthesis and characterization of new metal complexes 
of l,2-bis(sulphapyridyl)oxamide ligand. Kinetics and 
electrochemical studies of interaction of Co(II) 
complex with bovine milk casein. 
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CHAPTER III 
Experimental 
Sulphapyridine (Sigma) FeCh.eHjO, C 0 C I 2 . 6 H 2 O , CUCI2.2H2O and ZnCl2 (anhydrous) 
(BDH), and diethyl oxalate (Merck) were used as received. Microanalyses of the 
complexes were obtained on a Carlo Erba Analyzer Model 1106. Molar conductances 
were measured at room temperature on a Digisun Electronic Conductivity Bridge. I.r. 
spectra (200-4000 cm ') v\ere recorded on a Carl Ziess specord M-80 spectrophotometer 
in nujol mulls. The n.m.r. spectra were recorded on an amx-500 instrument. 
The cyclic voltammetric studies were carried out in phosphate buffer/DMF solution 
(95:5) of cobalt(ll) complex in the absence and in the presence of bovine milk casein 
(BMC). Kinetic experiments were performed under pseudo-first order conditions using a 
Systronic 119 spectrophotometer. The progress of the reaction was monitored by 
measuring absorbance changes at 278 nm (Amav of BMC) under vaiying concentrations of 
BMC. Pseudo-first-order rate constants. k<ihv ^^ere obtained by the linear least squares 
regression method. 
l ,2 -Bis(sulphapyridyl )oxamide |L] 
Sulphapyridine (5 g, 0.02 mol) in EtOH (100 mL) was added to diethyl oxalate (1.35 
g, 0.01 mol) in a 2:1 molar ratio. The solution was refluxed for ca. 1 h., then conc. HCl (6 
mL) was added dropwise with constant stirring. The resulting mixture was refluxed for 
51 
ca. 6 h. and kept overnight. The white crystalline product was obtained, which was 
filtered off under vacuum, washed thoroughly with Et20 and dried in vacuo. 
SYNTHESIS OF C O P P E R ( I I ) COMPLEX [ C 2 4 H 2 0 N 6 O 6 S 2 C U C I 2 ] 
A MeOH (30 mL) solution of the ligand L (0.552 g, 0.001 mol) and CUCI2.2H2O 
(0.170 g, 0.001 mol) was refluxed for ca. 2 h. The green precipitate, which was obtained 
after keeping the solution overnight at room temperature, was filtered off, washed with 
Et20 and dried in vacuo (Scheme I). 
SYNTHESIS OF I R O N ( I I I ) COMPLEX (C24H2ON606S2FECL2]CL 
Ligand L (0.552 g, 0.001 mol) in methanol (30 mL) and FeCb (0.270 g, 0.001 mol) in 
methanol (30 mL) were added together. The resulting solution was kept under reflux for 
ca. 3 h, A yellow precipitate, obtained after keeping the solution overnight at room 
temperature, was filtered off, washed with Et20 and dried in vacuo. 
SYNTHESIS OF COBALT(II) COMPLEX [C24H20N6O6S2C0CI2] 
To a solution of ligand L (0.552 g, 0.001 mol) in methanol (30 ml) was added 
C 0 C I 2 . 6 H 2 O (0.237 g, 0.001 mol) in methanol (30 mL). The resulting mixture was 
refluxed for 3 h, a pink product was obtained after keeping overnight in refrigerator. The 
product was filtered off, washed thoroughly with Et20 and dried in vacuo. 
SYNTHESIS OF Z I N C ( I I ) COMPLEX [C24H2ON606S2ZNCL2L 
To a hot solution of ligand L (0.552 g, 0.001 mol) in methanol was added ZnCl2 (0.136 g, 
0.001 mol) in methanol. The mixture was refluxed for ca. 2 h and the light brown 
5 2 
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Scheme 1 
precipitate, obtained after keeping the solution overnight at room temperature, was 
filtered off, washed with Et20 and dried in vacuo. 
Results and discussion 
The analytical data for the ligand and its complexes are listed in Table 3 and conform to 
the proposed structure (Scheme 1). The complexes are air stable, nonhygroscopic and are 
soluble in DMF/DMSO but insoluble in water and nonpolar organic solvents. Molar 
conductance measurements in 10'^ M DMF solution show that all complexes, except the 
iron(III) complex, are nonionic. 
I.R. spectra 
The 1,2-bis(sulphapyridyl)oxamide ligand [L] derived from sulphapyridine and 
diethyl oxalate (Table 4) shows a broad characteristic band at ca. 3440 cm"' due to v(N-
H) vibrations. This band is also observed in the complexes in ca. 3440-3444 cm"' range, 
indicating non-involvement of v(NH) in coordination. The bands attributed to the v(S02) 
group, that appear as sharp peaks at 1315 cm"', 1150 cm ' and 570 cm"' corresponding to 
Vasym, Vgym and scissors and wagging vibrations respectively, remain unaltered in the 
complexes as compared with the uncoordinated ligand [265], The characteristic bands of 
the pyridine ring at 1570 cm"', 610 cm"' and 420 cm. ' respectively arc attributed to in-
plane ring deformation and out-of-plane ring deformation in the free ligand (266-268]. 
Bands below 650 cm"' are sensitive to the coordination of pyridine through nitrogen to 
the metal atom. Thus, a strong band at 610 cm"' and a weak band at 420 cm"' shift to 
higher energy by ca. 56 cm"' and 10 cm"' respectively, upon coordination. The weak 
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pyridine ring deformation at 1570 cm"' is less sensitive to coordination and so this band 
remains unaltered and is superimposed on the 6 N H 2 deformation band [269.270], This 
type of coordination is reported for other transition metal complexes also [271-273]. The 
carbonyl frequency v(C=0) which appears at 1630 cm"' shifts to lower frequency by 
ca. 30 cm"' indicating involvement of the oxygen atom of the keto group in coordination. 
In the far i.r. region, the bands appearing at 460-490 cm"', 340-350 cm"' and 280-320 
cm"' are assigned to v(M-N), v(M-O) and v(M-Cl) respectively, further confirming 
coordination of the metal ion through the pyridine nitrogen and carbonyl oxygen atoms 
[274,275]. 
Electronic absorption spectra 
The electronic spectra of the l,2-bis(sulphapyridyl)oxamide cobalt(II) complex exhibit 
three bands at 25,000, 15,848 and 19,230 cm"'. A strong intense charge transfer band 
is shown at ca. 25,000 cm"' [276] (Figure 24). The assignments of the spectral bands are 
^T,g(F) • % g ( F ) and ^T,g(F) •^T,g(P) at ca. 15,848 and 19,230 cm"', respectively 
characteristic of an octahedral geometry [277]. The copper(II) complexes also exhibit a 
band at ca. 12,500 cm"' assigned to the ^ E g — • ^T2g transition, suggesting an octahedral 
geometry. A strong charge transfer is observed at 36,931 cm"' [278], The electronic 
spectra of the iron(III) complexes are expected to show four absorption bands 
corresponding to the transitionsi^Aig •^Tig, ^A]g •"Tag, ^Aig •{ '^Aig, ^Eg} 
and ^Aig •' 'T2g(D) but all these transitions are not generally observed. We have 
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Figure 24. Representative electronic spectrum of the cobalt(ll) complex of 1,2-
bis((sulphapyridyl)oxamide. 
observed three absorption bands at 25,380, 29,650 and 30,864 cm"' assigned to 
^Aig • '*T2g. ^Ajg • C^Aig, '^Eg} respectively, and to a charge-transfer band 
indicating the octahedral geometry of the iron(III) complex [279]. 
E.p.r. studies 
The e.p.r. spectrum recorded at room temperature of the powdered copper(II) complex 
reveals g values at (gi = 2.21 and gn = 2.28), respectively. The observed g values indicate 
the presence of an unpaired electron in the dx^-^^ orbital, a phenomenon reported for 
octahedral complexes [280]. In the present complex gn < 2.3 which clearly indicates the 
covalent nature of the complex [281]. 
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N M R studies 
The 1.2-bis(sulphapyridyl)oxamide ligand and its zinc(II) complex were characterized by 
H n.m.r. and ' 'C n.m.r. spectroscopy. In 'H n.m.r. spectrum of the ligand, a multiplet 
has been observed at 7.73-8.06 p.p.m. corresponding to the pyridine ring protons [282], 
All the benzene ring protons have been observed in the range of 6.90-7.16 p.p.m [283]. 
Spectrum does not show the signal attributed to the NH proton indicates the 
deprotonation of NH proton of sulphonamide and its subsequent participation in the 
ligand formation. '^C n.m.r. spectrum of the ligand exhibits pyridine ring carbons at 140 
p.p.m. and benzene ring carbons at 129 p.p.m., respectively [284]. The ligand shows a 
characteristic signal at 160 p.p.m. for >C=0 [285] which supports the formation of 1,2-
bis(sulphapyridyl)oxamide ligand. 
'H n.m.r. spectrum of the zinc(Il) complex sho\\s a significant shift in pyridine ring 
protons in comparison to the ligand which reveals the coordination of metal ion through 
the N atom of pyridine ring while NH; protons remain unaltered [286] (Table 5). '^C 
n.m.r. spectrum show signals at 128, 132 and 118 p.p m due to the benzene ring, C-SO2-
N and -C-NH: carbons AH the pyridine ring and >C=0 carbon signals have been 
observed at 145 p.p.m. and 158 p.p.m., respectivcl> (Table 6). 
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Electrochemical properties 
The cyclic voltammogram of the l,2-bis(sulphapyridyl)oxamide cobah(II) complex in 
buffer/DMF solution (95:5), recorded at the scan rate of 0.1 Vs"', reveals one reversible 
redox wave attributed to cobalt(II)/cobalt(I) couple at E° values of -0 .622 V and 
-0.502 V respectively, [287] (Figure 25a). The easy reversibility of the process can be 
7 8 
explained as both low-spin cobalt(II) (d') and cobalt(I) (d°) prefer an axially distorted 
geometry [288]. At different scan rates (Figure 25b), there is no change in the redox 
pattern, clearly indicating that E° is independent of scan rate, i.e. the criteria of 
reversibility [289]. On interaction of the cobalt(II) complex with BMC, the E° values 
shift to negative potential (E° = -0.908 V and -0.703 V), respectively at the same scan 
rate (Figure 26a) which clearly indicates strong binding of the BMC with the cobalt(II) 
complex. An increase in scan rate has a negligible effect on E° (Figure 26b). On the basis 
of electrochemical data and kinetic studies, the following mechanistic pathway is 
proposed: 
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The cyclic voltammograms of the cobalt(II) complex, bound to BMC, were recorded at 
different pH's (Figure 27a). The plot of values versus pH was pH-dependent 
(Figure 27b) and at 7.4 pH, the values are maximal indicating good interaction 
between BMC and the cobalt(II) complex, which is further supported by kinetic data . 
Kinet ic s tud ies 
All kinetic studies were carried out in phosphate buffer solution at different pH's, 
observing the absorbance changes by employing u.v/vis spectroscopy. The changes in the 
u.v. spectrum were monitored at 278 nm (X,max for BMC) with respect to time, and pseudo 
first order rate constants, kobs, were obtained from the slope and intercept of the straight 
line. The absorbance changes with varying concentrations (c = 10-14 x 10'^ M) of BMC 
in buffer solution at a fixed concentration of the cobalt(II) complex (c = 1 x 10-^  M) were 
recorded at different time intervals at room temperature with varying pH. (Figure 28a-c). 
The rate constants, k^bv were determined at different pH's (7.4, 6.5 and 5.5) using the 
least squares regression method (Figure 29). The plot of absorbance versus time at 
different pH's was linear up to 80% completion of reaction and these data gave rise to the 
pH-rate profile as in (Figure 30). The kinetic data hold good for following rate law 
k,,bs = k , k : ( B M C ] / [ k . , + k2] 
The values of k„bs. indicate the first order reaction kinetics and is pH dependent. At higher 
pH, the kobs. values rise sharply indicating the strong binding of BMC to the cobalt(II) 
complex. 
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CHAPTER IV 
Template synthesis of Co(II), Ni(II) and Cu(II) complexes 
derivedfrom oxamide ligand and the reactivity of Cu(II) 
complex towards human serum albumin. 
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CHAPTER-IV 
Experimental 
Iminodiacetic acid, diethyl oxalate (Merck), C 0 C I 2 . 6 H 2 O , NiCb 6 H 2 O and CUCI2.2H2O 
and triethylene tetramine (BDH), were used as received. Microanalyses of the complexes 
were obtained on a Carlo Erba Analyzer Model 1106. Molar conductances were 
measured at room temperature on a Digisun Electronic Conductivity Bridge. I.r. spectra 
(400-4000 cm"') were recorded on a Carl Ziess Specord M-80 spectrophotometer in KBr. 
'11 and ' 'C n.m.r. spectra were recorded on an amx-500 instrument. The electrochemical 
behaviour of the Cu(Il) complex and its interaction with HSA were monitored by cyclic 
voltammetr)' in phosphate buffer. 
Ihe kinetic experiments were performed under pseudo-first order conditions and the 
spectral ciianges were recorded at 278 nm (knw\ of HSA) with respect to time using a 
Systronic 119 spectrophotometer. 
Synthesis of the ligand 2,2'-(oxalydimino)bis(diacetic acid)[CioHi20joN2],[L] 
Iminodiacetic acid (5 g. 0.037 mol) in water (10 mL) was added to diethyl oxalate 
(2.55 g, 0.019 mol) in a 2:1 molar ratio. The above solution was refluxed for ca. 6 h and 
then conc. HCl (6 mL) was added dropwise with constant stirring. The resulting solution 
was refluxed for ca. 48 h and allowed to cool overnight in refrigerator. A white 
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amorphous product was obtained, filtered, washed thoroughly with Et20 and dried in 
vacuo. 
Synthesis of the complex 3,3',6,6' tetraazadodeca I-I 'di imino N,N fetraacetic 
acid copper(II) chloride [CigHifeNfiOsCuJCIz 
The Jigand L (0.640 g 0.002 mol) in ethanol (50 mL) was refluxed with Cu(II) complex 
of triethylenetetraamine (0.558 g. 0.002 mo!) in ethanol, which was prepared by the 
earlier reported method [290]. The resulting solution was boiled under reflux for ca. 6h. 
The reaction mixture was then allowed to stand in refrigerator for ca. 24 h. Dark blue 
colored powder was obtained, which was filtered off, washed with Et20 and dried in 
vacuo. Scheme 2. 
Synthesis of the complex 3,3',6,6' tetraazadodeca l - r d i i m i n o N , N tetraacetic 
acid cobalt(II) chloride [C,6H26N608Co|Cl2 
A solution of ligand L (0.640 g, 0.002 mol) dissolved in hot ethanol (50 mL) was 
refluxed with Co(II) complex of triethylenetetraamine (0.548 g, .002 mol) in ethanol. The 
mixture was refluxed for ca. 8 h and allowed to cool overnight in refrigerator. A pink 
precipitate was obtained after filtration and washed thoroughly with Et20 and dried in 
vacuo. 
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Synthesis of the complex 3,3',6,6' tetraazadodeca 1 - r d i i m i n o N,N tetraacetic 
acid nickel(II) chloride [CieHieNfiOgNilCh 
The ligand L (0.640 g, 0.002 mol) in ethanol (60 mL) was refluxed with Ni(II) complex 
of triethylenetetraamine (0.548 g, 0.002 mol) in ethanol. The resulting solution was 
boiled under reflux for 9 h. The reaction mixture was then allowed to stand in refrigerator 
for overnight. Green colored powder was obtained, which was filtered off, washed with 
Et20 and dried in vacuo. 
Results and discussion 
I.R. spectra 
The characteristic i.r. bands are listed in Table 8. The i.r. spectra of the ligand exhibits 
two medium intensity bands at 1577 and 1498 cm"' corresponding to antisymmetric and 
symmetric COO" stretching vibrations, respectively [291]. These bands remains unaltered 
in the complexes indicating non-involvement of v(COO") in coordination. Two sharp 
absorption bands at 1080 and 1300cm'' assigned to v(C-C) and v(C-N) vibration were 
observed in the free ligand and the complexes as well. 
The characteristic carbonyl band v(C = O) observed at 1680 cm"' in the free ligand [292], 
disappear in the complexes and a new intense band appears in 1580-1610 cm"' region for 
all the complexes assigned to the C = N stretching vibration [293]. However, the C = N 
stretching frequency appears at a lower wave number, decrease in v(C = N) in the 
complexes is indicative of coordinated nitrogen atoms [294,295]. The far i.r. spectra 
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exhibits v(M - N) stretching bands in 468-470 cm"' range which further support the 
coordination of metal ion through nitrogen atom [296]. 
Electronic absorption spectra 
The electronic spectra of the Cu(II) complex exhibit two bands at 32,573, and 
16,666 cm"'. The assignments of the spectral band at 16,666 attributed to 
^Big • ^Eigand •^Aig cm"'transitions [297] and the other band at 32,573 
cm"' correspond to a ligand to metal charge transfer band (MLCT) respectively [298] 
(Figure 31). The presence of this charge transfer band in visible region has been 
attributed to a square planar arrangement around the Cu(ll) center [299]. 
The Co(II) complex also exhibits intense bands in high energy region 33,220-26,525 
cm "' which are assigned to charge transfer M • L bands. The two low energy 
bands are identified at 20,080 and 19,521 cm"' due to ^A|g Eg transition indicating 
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Figure 31. The representative electronic spectra of Cufll) complex. 
square planar geometry [300], The electronic spectra of Ni(II) complex also shows two 
bands at 26,455 and 16,886 cm"'. The band at 26,455 cm"' has been assigned to 
'Aig • 'Big transition [301,302], A single intense d-d characteristic band at 
16,886 cm"' is attributed to diamagnetic square planar Ni(II) complex [303-305]. 
EPR spectra 
The e.p.r. spectra of the Cu(II) complex, recorded at 30 "^C, shows a signal for gn and 
gi at 2.16 and 2.05 respectively. The existence of gn > g i suggests that d^.-.y is the 
ground state for the d9 [Cu ] configuration i.e. (eg^) (a,g)2 (bjg) ' (b,g)' [306], The g 
values are related to the axial symmetry parameter G by the expression G = (gn - 2/ gi- 2) 
[126]. The g value measures the extent of exchange interaction between the copper 
centers in polycrystalline solids. If G < 4, considerable exchange interaction occurs and if 
G > 4, exchange interaction is negligible. In the present case, G appears to be greater 
than 4, which shows that exchange interactions are absent in the complex. The 
presence of gn > g i in the spectrum of the Cu(II) complex is an authentic evidence for 
square planar geometry around the copper(II) atom [307]. 
NMR studies 
NMR is an important tool for characterization of the compounds. For structure 
elucidation of the [C10H12O10N2] and [Ci6H26N608Ni]Cl2, 'H and '^C n.m.r. spectra were 
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recorded (Table 9 and 10). 'H n.m.r. spectrum of the ligand recorded at 300 MHz at room 
temperature in D2O exhibits characteristic signals of -CH2 and - C O O H protons at 
3.0-3.2 p.p.m. and 11.01 p.p.m., respectively [308, 309], which indicate that - C O O H 
group of iminodiacetic acid is not involved in the synthesis of oxamide ligand. This is 
also confirmed by the absence of NH proton at 5.9 p.p.m. [310]. '^C n.m.r. spectrum of 
the ligand exhibits the signals at 167.23, 158.59 and 27.54-30.96 p.p.m. for - C O O H , 
and -CHT carbons, respectively. 
In 'H n.m.r. of the complex [Ci6H26N608Ni]Cl2 signal appears at 5.6 p.p.m. for NH 
proton, which is indicative of the complex formation and condensation > C = 0 groups of 
the oximide ligand [C10H12O10N2] with -NH2 groups of tetraamine Ni(II) complex 
[C6Hi6N4Ni]Cl2 The appearance of the signal at 11.01 p.p.m. for - C O O H proton clearly 
indicates that -COOH groups are not involved in interaction. The multiplet due to -CH2 
protons was observed at 3.70-3.90 p.p.m. 
'^C n.m.r. of the complex [Ci6H26N60gNi]Cl2. shows a signal at 174.21 p.p.m. which is 
due to carbons of the group -C=N. Other resonances have been observed at 167.23 and 
30.96-27.54 fo r -COOH and ^ H ; carbons, respectively. 
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Redox behaviour 
The redox behaviour of the Cu(II) complex was studied by cychc voltammetnc 
measurement in phosphate buffer The cychc voltammogram of Cu(II) complex exhibits 
one electron quasi-reversible redox couple corresponding to the Cu'VCu' with Ep values 
- 0 730 and - 0 560V, respectively at a scan rate of 0 1 Vs"' (Figure 32a) For this couple, 
the difference between cathodic and anodic potential AEp is of the order 128 mV and the 
Ipa/Ipc value IS less than one At dillerent scan rates (Figure 32b], there is no major 
change in Ep and E1/2 values clearly indicating that Ep is independent of scan rate For a 
reversible/quasi-reversible wave Ep is independent ot scan rate and Ip is proportional to 
v"^ [311, 280] On interaction of the Cu(II) complex with HSA there is a slight shift in 
Ep values of - 0 799 and - 0 541 V respectivel}, at the same scan rate (Figure 33a) 
suggesting the binding of HSA with the Cu(II) complex but as the shifts in formal 
potential of the complex are not so significant (Figure 33b) therefore, it is inferred that 
the Cu(II) complex exhibits reduced binding for serum albumin 
The cyclic voltammogram of the Cu(II) complex bound to HSA was recorded at different 
pH's (6 0-7 4) The Figure 34 shows the plots of Ep \ersus plFs At lower pH 6 0 1 " 
values are lowest due to partial involvement of imidazole nitrogen of HSA 1 he pi I 
dependence in histidine-metal interactions has also been demonstrated earlier [312] 
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Figure 32. (a) Cyclic voltammogram of Cu(II) complex in phosphate buffer at 30°C at a 
scan rate of 0.1 Vs''. (b) Cyclic voltammogram of Cu(II) complex in 
phosphate buffer at 30"C at different scan rates viz. 0.1, 0.2 and 0.3 Vs'. 
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Figure 33 . (a) Cyclic voltammogram of Cu(II) complex bound with HSA in phosphate 
buffer at SO^C at a scan rate of 0.1 Vs''. (b) Cyclic voltammogram of Cu(II) 
complex bound with HSA in phosphate buffer at 30°C at different scan rates 
viz. O.I, 0.2 and 0.3 Vs'. 
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Protein HSA binding studies 
The u.v./vis spectrum of Cu(II) complex in phosphate bufiei reveals a M-L charge 
transfer band at 307 nm and a d-d transition at 662 nm 
Interaction of Human Serum Albumin with the Cu(II) complex was studied at Xm3\ of 
HSA (278 nm) under pseudo first order conditions The ahsoibanee changes uith var\mg 
concentrations (c = I x 10 to 5 x 10"^  mol dm"^) of HSA in buller solution were recorded 
at fixed concentration of the Cu(II) complex ( c = 0 5 \ 10 ^ mol dm ') at the diHcrent 
time intervals at 30°C . After the addition of HSA at the dilieient tunc intervals (1 igurc 
35), there is steep decrease in absorption intensity indicatne of Inpochromicity houcxcr. 
no band shift has been observed. The spectral evidence support the binding of HSA to the 
Cu(II) complex but as the absorbance spectra does not record any shift in the 
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wavelength, the reduced binding or low binding affinity for HSA is concluded. The 
rational design of compounds with reduced albumin binding has been limited due to lack 
of binding data to albumin active sites. These results are important "to understand the 
structure affinity relationship of metal complex-albumin interaction [37]. 
The rate constants, kobs, were determined using the least squares regression method 
(Figure 36, 37). The plot of k<,bs versus [HSA] is linear suggesting pseudo first order 
reaction kinetics. 
The following rate law holds good 
kobs = k,k2[HSA]/[k., + k2] 
2 9 0 . 0 
Wavelength (nm) 
Figure 35. Electronic spectra of the Cu(II) complex in the presence of HSA with respect 
to time at 0.5X 10'^ M. 
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Figure 36. (a) Plot of logA versus time at varying concentrations (c = 1-3 x 10'^ M) of 
HSA at 6.0 pH. (h) Plot of logA versus time at varying concentrations 
(c = 1-3 X W'^ M) of HSA at 6.5 pH 
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Figure 36. (c) Plot oflogA versus time at varying concentrations (c = 1-3 x /O"' M) of 
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pH Profile 
We have also studied the reaction kinetics of the Cu(n) complex in presence of HSA at 
different pH's values and consequent changes in absorption spectra were observed 1 here 
is a negligible change in the absorbance spectra in 6 0 - 7.4 pH range At pH 7 4 the 
absorption spectra does not show any shift although a high maxima is observed mdicatmg 
that the interaction between the complex and serum albumin is weak. However as the pH 
values decreases, the intensity of the absorption peak at 278 nm (?^ max of HSA) decreases 
indicating that the coordination of the Cu(ll) complex to serum protein may take place 
through imidazole side chains of surface exposed histidine of protein [313]. 
The plots of AOBS versus HSA at different pH"s give a straight line suggesting that all the 
reactions are of pseudo-first order type (Figure 38). 
c 
E 
- 4.83 
- X 
n 
I 383 ^ 
283 
Figure 38. pH-rate profiles of Cu(ll) complex bound with HSA. 
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CHAPTER V 
New borate complexes of dihydro 00*bis(salicylidene) 
2,2' aminobenzothiazolyl and the interaction of 
dimethyltin copper complex with guanine, adenine and 
calf thymus DNA, 
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CHAPTER V 
Exper imen ta l 
All the reagents 2-aminobenzothiazol (Farak berlin, Germany), salicylaldehyde, KBH4 
(Lancaster), Calf thymus DNA, guanine, adenine (Sigma), (CH3)2SnCl2 (Fluka), 
CUCI2.2H2O and ZnCl2 (anhydrous) (Merck) were used without further purification. 
Microanalyses were performed by a Carlo Erba Analyzer Model 1108. Molar 
conductance was determined at room temperature by a Digisun Electronic conductivity 
Bridge. IR spectra (Nujol mull) (200-4000 cm"') were recorded on a Shimadzu 8201 PC 
spectrophotometer. 'H and '^C n.m.r. spectra were recorded by Bruker DRX-300 
spectrometer. E.P.R. spectra was recorded on a Varian El 12 spectrometer at X-band 
frequency (9.1 GHz) at liquid nitrogen temperature (LNT). 
The cyclic voltammetry of the complex C32H34N4S203BCuSn2Cl5 was studied in the 
absence and in the presence of guanine, adenine and calf thymus DNA. Kinetic studies of 
the complex C32H34N4S203BCuSn2Cl5 with guanine, adenine and calf thymus DNA were 
carried out on a Cintra 5 UV-VIS spectrometer attached to an on line data analyser on 
which absorption spectra were evaluated. 
Synthesis of Schiff base ligand 
To a solution of 2-aminobenzothiazol (5g, 0.033 mol) in 50 mL of methanol was added 
(3.49 g, 0.033 mol) salicylaldehyde. The reaction mixture was refluxed for 3 h. Yellow 
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precipitate appears immediately on cooling which was separated by filtration, 
recr\'stallised from methanol and dried in vacuo over fused CaCl2. 
Synthesis of the d ihydro 00 'b is (saI icyUdene)2 ,2 ' aminobenzothiazoiyl bora te 
To a solution of Schiff base (4.7 g, 0.018 mo!) in 100 mL dry DMF was added KBH4 
(0.5g, 0.009 mol). This reaction mixture was refluxed for ca. 10 h in a closed assembly 
fitted to monitor the evolution of H2 gas. During the course of refluxing the reaction 
mixture, the solution changes colour slowly from dark yellow to colorless and later turns 
brown. After 10 h, the evolution of hydrogen gas ceased and light brown colored product 
appeared in the reaction flask. The product was filtered and washed twice with toluene 
and dried in vacuo over fused CaC^. 
Synthesis of [C28H22N4S2O3BCUCI] 
The borate ligand (1.03 g, 0.002 mol) in 50 mL methanol was treated with CuCb. 2H2O 
(0.340 g, 0.002 mol). The reaction mixture was stirred for 2 h and then allowed to stand 
overnight in refrigerator. A brown product separates out which was isolated by filtration 
under vacuum, it was washed thoroughly with hexane and dried in vacuo over fused 
CaCb 
Synthesis of (C28H22N4S20jBZnCI] 
To a heated solution of the borate ligand (1.03 g, 0.002 mol) in 50 mL of methanol was 
added ZnCl2(0.27 g, 0.002 mol) in the same solvent. The solution was allowed to stir 
9 0 
^ N H , 
- N 
- H P 
-^—CH 
N + KBH4 
- H 2 D M F 
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Schemes 
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for 4 h, when a reddish brown precipitate appeared and was isolated with filtration under 
vacuum. It was washed thoroughly with hexane and dried in vacuo over fused CaCb. 
Synthesis of [C32H34N4S203BCuSn2Cl5] 
To a solution of C2SH22N4S2O3BCUCI (0.634 g, 0.001 mol) in 40 mL DMF was added 
(CH3)2SnCl2 (0.438 g, 0.002 mol) in 1:2 molar ratio. The reaction mixture was refluxed 
for 48 h on a water bath. A dark brown precipitate appears, which was isolated filtered 
off, washed with hexane and dried in vacuo over fused CaC^ (Scheme 4). 
Synthesis of [C32H34N4S203BZnSn2Cls] 
Zinc complex [C28H22N4S203BZnCl] (0.636g, 0.001 mol) was dissolved in 30 mL of 
DMF and treated with (CH3)2SnCl2 (0.438 g, 0.002 mol) in the same solvent. The 
solution was refluxed for 48 h on a water bath. A dark brown precipitate appears, which 
was isolated filtered off, washed with hexane and dried in vacuo over fused CaC^. 
Result and discussion 
The reaction of Schiff base with KBH4 in 2:1 ratio yielded dihydro 0 0 ' bis(salicyidene) 
2,2' amino benzothiazolyl borate, which was utilized as a ligand for complexation with 
CuCb, ZnCl2 and subsequent complexation of C28H22N4S2O3BCUCI and 
C2gH22N4S203BZnCl with dimethyltindichloride yielded the bimetallic borate complexes 
C32H34N4S203BCuSn2Cl5 and C32H34N4S203BZnSn2Cl5, respectively. All the complexes 
are air stable and are soluble in DMF, DMSO. The analytical data of the complexes 
(Table 11) conform to the structures proposed in scheme 4. 
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I.R. spectra 
The important i.r. bands are depicted in Table 12. The infrared spectrum of the ligand 
shows prominent stretching vibration at 2372-2400 cm"' region due to v(B-H). The BH 
stretch generally appears as a single peak in the regions 2400-2500 cm"' but the presence 
of both and " B in natural boron results in splitting of bands [313, 314], Other 
characteristic frequencies due to the presence of the ligand appear at 1595 cm"', 
1449 cm"' and 752 cm"' assigned to v(C==N), v(C-N) and v(C-S) vibration, respectively 
[315-317]. The formation of borate is authenticated by appearance of v(B-O) band at 
1391 cm"' [318,319] which is further confirmed by absence of v(O-H) stretching 
vibration at 3422 cm"' which was present in the Schiff base [320]. The v(B-O) band 
however, shifts to higher frequencies (28 cm"') in the complexes indicating the 
participation of oxygen of borate in the formation of complexes. 
In the far i.r. spectra of the monometallic complexes sharp absorption bands appearing at 
390-400 cm"', 310-320 cm"' are assigned to v(M-O) and v(M-C!) vibration, respectively 
[321,322]. The bimetallic complexes show absorption bands at 420, 546 and 
462 cm''assigned to v(Sn-N), v(Sn-C) and v(Sn-CI) respectively, confirming the 
coordination of tin(lV) center to azomethine nitrogen and chlorine atoms [323,324]. 
Electronic absorption spectra 
The electronic absorption spectra of the borate ligand and complexes reveals three strong 
bands in 40,000-25,000 cm ' region which are attnbuted to intraligand and charge 
transfer transitions 
The C28H22N4S2O3BCUCI complex exhibits a broad and low energy band at 16,528 cm"' 
which is attributed to d-d transition (^Big—•^Aig), typical for Cu" in square-planar 
environment. The absorption spectrum of the C28H22N4S2O3BCUCI complex exhibits two 
MLCT bands at 34,013 cm"'and 30,303 cm"' and a broad band at 17,361 cm"' attributed 
to d-d transition which is typical for copper(II) complex in square planar geometry [325]. 
Although, there is a shift in the d-d absorption band of the C32H34N4S203BCuSn2Cl5 
complex in comparison to the absorption band observed for the C28H22N4S2O3BCUCI 
complex which is attributed to the presence of Sn(IV) metal ion, the environment around 
the copper center does not alter much, it retains square planar geometry. 
E . P . R . s tudies 
The solid state X-band e.p.r. spectrum of the C32H34N4S203BCuSn2Cl5 complex recorded 
at liquid nitrogen temperature LNT (77 K) was found to be anisotropic with only two 
peaks with 'g ' values g^ = 2.037, gy = 2.195 and gav = 2.089, respectively. The parameter 
gav was obtained according to the equation [(gav) = 1/3 (g|| + 2gi )] and is in good 
agreement with corresponding anisotropy in square-planar environment. The existence of 
g[l > gx suggested that the unpaired electron is localized in dx -^y^ orbital of the Cu" ion 
with "3d^ configuration i.e., (eg)"*, (aig)^ (bjg)^ (big)' which is the characteristic of the 
square-planar geometry [306]. 
The g values are related to the axial symmetry parameter, G, by the Hathaway [326,327] 
expression G = (gn -2)/(gi-2). According to Hathaway, if the value of G is greater than 
four, the exchange interaction is negligible, whereas when the value of G is less than 
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four, a considerable exchange interaction is indicated in the complex. In the complex 
C32H34N4S203BCuSn2Cl5_ G value obtained was 5.27 which indicates that exchange 
interactions are absent. 
N . M . R . s tud ies 
'H NMR spectra is particularly useful to confirm the formation of borate ligand 
(Table 13). The absence of phenolic - O H resonance peak at 12.5 p.p.m. in the ligand 
clearly indicates the formation of borate by removal of hydrogen gas [328] and presence 
of BH2 signal at 0.84 p.p.m. [329]. The other signals due to N=CH proton and aromatic 
ring proton appear at 7.99 and 7.55-6.52 p.p.m., respectively. In the complexes 
C28H22N4S203BZnCl and C32H34N4S203BZnSn2Cl5, there is slight upfield shift in BH2 
signal due to presence of metal ions in the proximity of BH2 protons. A new signal 
appears in the complex C32H34N4S203BZnSn2Cl5 at 1.21 p.p.m. due to methyl protons of 
the dimethyl tin moiety. 
'^C NMR spectra of ligand has been recorded in DMSO and carbon resonance signals 
appears at 129-124, 165, 153 and 114 p.p.m. assigned to aromatic phenyl ring carbons, 
HC=N, C-S and C-N groups, respectively. Upon complexation, there is a slight shift in 
aromatic ring carbon resonance due to the coordination of metal to the oxygen atom of 
phenyl ring. Furthermore complex C32H34N4S203BZnSn2Cl5, registers a new signal at 
33.8 p.p.m attributed to -Sn-CHs carbons due to which CH=N carbon resonance gets 
altered slightly, this is also an indication of coordination of azomethine nitrogen to the 
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diorganotindichloride. Other carbon signals remain unaltered in the complexes 
(Table. 14). 
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Figure 39. ^^  C NMR spectra of (a) the ligand [C28H20N4S2O2B] and (b) complex 
[C32H34N4S203BZnSfl2Cl5j, 
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Elec t rochemica l p rope r t i e s 
The electrochemical beha\ lor of the complex C32H34N4S203BCuSn2Cl5 has been 
examined by cyclic voltammetry to study the metallointeraction. The cyclic 
voltammogram of the complex C32H34N4S203BCuSn2Cl5 in absence of guanine, adenine 
and calf thymus DNA was recorded in DMSO/H2O (5:95) at a scan rate of 0.1 Vs"' in the 
potential range -1.2 to 1.6 V versus Ag/AgCl electrode. It exhibits a well defined 
quasireversible redox \ \ a \e Cu'VCu' attributed to one electron transfer process with Ep 
value at -0.615 V and -0.519 V (Figure 40, curve a). For this couple, the difference 
between the cathodic and anodic peak potentials, AEp is of the order 96 mV, a somewhat 
large peak to peak separations in comparison to Nemstian value (59 mV) observed for 
one electron transfer couple. Large peak width for one electron couple Cu" ^ Cu' is 
fairly common observation and is due to the reorganization of the coordination sphere 
during the electron transfer process [330,331]. The ratio of anodic to cathodic peak 
currents, Ipg/Ipc is less then the unity (0.3). The criteria for reversibility of the process is 
satisfied as on increasing the scan rate, the voltammogram does not show any significant 
change and current is proportional to V"* (Figure 41) [280]. 
The electrochemical beha\ior of the complex C\;H34N4S:O^BCuSn2CU in presence of the 
guanine, adenine and calf thymus DNA in DMSO/Buffer. DMSO/H2O and DMSO/Tris-
buffer, respectively are presented in Table 15. 
The c. v. trace of the complex C32H34N4S203BCuSn2Cl5 in presence of guanine shows a 
dramatic change in electrode potential Ep \alues. while the cathodic peak 
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potential shifts to -0.669 V (in comparison to solution without guanine Ep = -0.615 V) a 
positive shift of -0.054 V is observed. However, the anodic peak disappear completely 
(Figure 40, curve b) indicative of strong binding of the complex to guanine base via. 
intercalation mode and suggest the possibility of interaction of Cu(II) form with guanine. 
The cyclic voltammogram of the complex C32H34N4S203BCuSn2Cl5 in presence of 
adenine shows a slight shift in formal potential values (in comparison to the solution in 
absence of adenine) (Figure 42, curve c). Although it corresponds fairly well with quasi 
reversible one electron redox couple but peak potential does not show any significant 
change (0.002 and 0.003 V). The c.v. trace of adenine bound complex clearly suggests 
the binding of the complex C32H34N4S203BCuSn2Cl5to adenine is possible but the degree 
of binding is much lower in comparison to guanine. This observation supports the 
possibility of binding of the complex C32H34N4S203BCuSn2Cl5 more favorably to 
guanine base rather than to adenine base in nucleotides of DNA backbone. 
However, the cyclic voltammogram of the complex C32H34N4S203BCuSn2Cl5 in presence 
of calf thymus DNA (Figure 43, curve d) shows a significant shift in electrode potential 
value, cathodic and anodic peak potentials both shift to positive values -0.642 V and 
-0.561 V while for (the solution of the complex C32H34N4S203BCuSn2Cl5 in absence of 
calf thymus DNA, electrode potential values are a -0.615, -0.561 V as depicted in Figure 
40, curve a) indicating that both the copper(II) and copper(I) form interact with calf 
thymus DNA to the same extent and suggest strong binding with calf thymus DNA [332]. 
Employing a square redox scheme, the net shift in £,,7 has been estimated from the ratio 
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of equilibrium constants for the binding of Cu" and Cu' complexes to calf thymus DNA 
using the following equation 
Cu "+e" 
/ 
K2+ 
Cu"-CTDNA+e 
Cu' 
KH 
Cu'-CTDNA 
E ' ^ - E " ' ' - 0 . 0 5 9 1 log (K,VK2+) 
where E'^ ^ and E'^ ' were formal potentials of the Cu(II)/Cu(I) couple in the free and 
bound forms, respectively. The ratio of binding constant of K2+ and Ki+ were 
corresponding binding constants for the Cu(II)/Cu(l) species to DNA, respectively [333]. 
The ratio of binding constants of 1+ and 2+ species was less than 1 (0.670 for calf 
thymus DNA) which provides an evidence for the preferential stabilization of Cu(II) 
species. 
The electrochemical behavior which we witnessed during interaction of complex 
C32H34N4S203BCuSn2Cl5 with guanine, adenine and calf thymus DNA suggest that the 
complex C32H34N4S203BCuSn2Cl5 interacts with guanine possibly through stabilization 
of copper(II) form only while adenine shows binding to a lesser degree and complex-calf 
thymus DNA interaction is strongest with the stabilization of both form 
copper(Il)/copper(I) and their involvement in DNA binding is evident. 
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Figure 40. Cyclic voltammograms of the complex C32tii4N4S20sBCuSn2Cl5in the (a) 
absence and (b) presence of guanine in DMSO/buffer (5:95) at a scan rate of 
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Figure 41. Cyclic voltammpgrams of the complex Ci2Hi4N4S20iBCuSn2Cls at various 
scan rates viz. 0.1, 0.2 and 0.3 Vs'^. 
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Figure 42. Cyclic voltammograms of the complex C32H34N4S2OSBCUSH2CI} in the (a) 
absence and (b) presence of adenine in DMSO/H2O (5:95) at a scan rate of 
0.1 Vs"'. 
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Figure 43. Cyclic voltammograms of the complex C32H34N4S203BCuSn2Cls in the (a) 
absence and (b) presence of calf thymus DMA in DMSO/buffer (5:95) at a 
scan rate of 0.1 Vs''. 
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Kinetic studies 
The interaction of the complex C32H34N4S203BCuSn2Cl5 with guanine, adenine and calf 
thymus DNA in DMSO/Buffer, DMSO/H2O and DMSO/Tris-buffer, respectively was 
studied spectrophotometrically at 25°C under pseudo first-order conditions. 
The electronic absorption spectrum of free guanine exhibits two characteristic bands at 
244 nm and 273 nm. On addition of the complex C32H34N4S203BCuSn2Ci5, the u.v. band 
at 273 nm increased in intensity and shifts to 269 nm (a shift of 4 nm is observed) as 
shown in Figure 44. The binding of guanine with the complex C32H34N4S203BCuSn2Cl5 
results in blue shift and increase in intensity which is attributed to "hyperchromism". 
Hyperchromism was due to the breakage of intermolecular hydrogen bonds when bound 
to DNA and is consistent with many earlier reports for copper complexes [334,335], It 
further confirms the selective binding of the complex C32H34N4S203BCuSn2Cl5 with 
guanine preferably with N7 position. 
Kinetics of guanine binding to the complex C32H34N4S203BCuSn2Cl5 was studied at 269 
nm (Xmax of the complex C32H34N4S203BCuSn2Cl5 + guanine) under pseudo first order 
condition keeping the concentration of complex constant (c = 1 X 10"^  M) and varying 
the concentration of guanine (c = 10-16 X 10"^  M) at different time intervals. Figure 44 
shows the time-scanning spectra from a series of reactions between guanine and the 
complex C32H34N4S203BCuSn2Cl5 at 269 nm which reveal systematic increase in 
absorbance. The rate constants, kobs, were determined by the linear least squares 
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regression method. An exponential log(Aa-Ao) of absorbance against time plots gave a 
straight line indicative of pseudo first-order reaction (Figure 47 a). 
The electronic absorption spectrum of adenine shows a characteristic uv band at 260 nm. 
On addition of the complex C32H34N4S203BCuSn2Cl5, there is no significant shift in 
wavelength and a slight increase in absorbance (Figure 45). Although a slight 
hyperchromism is observed but the degree of hyperchromism is insignificant in 
comparison to the binding of guanine to the complex C32H34N4S203BCuSn2Cl5 which 
shows relatively weak interaction with adenine base. 
Kinetics of adenine binding to the complex C32H34N4S203BCuSn2Cl5 was carried out at 
260nm (X a^x of complex C32H34N4S203BCuSn2Cl5 + adenine) under pseudo first-order 
conditions. Figure 47 b. shows time scan plot of interaction of adenine with complex 
C32H34N4S203BCuSn2Cl5 depicting a small change in absorbance intensity. The rate 
constant, k<,bs, values were plotted by linear least squares regression method. The obtained 
reaction profile reveals a less pronounced kinetic influence from the calf thymus DNA, 
indicative of weak electrostatic interaction. 
The kinetics of interaction of the complex C32H34N4S203BCuSn2Cl5 with calf thymus 
DNA was carried out to obtain detailed information concerning the magnitude of the 
kinetic influence from the DNA environment as a function of position of guanine N7 
within calf thymus DNA. 
The kinetics of interaction of the complex C32H34N4S203BCuSn2Cl5 to the calf thymus 
DNA was carried out at 260 nm {X ,^^  of calf thymus DNA) under pseudo-first order 
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conditions (Figure 47 c). On addition of the complex C32H34N4S203BCuSn2Cl5 to the calf 
thymus DNA, absorption spectra reveals a sharp change in absorption intensity with a red 
shift of 3 nm. At different time intervals (Figure 46) the absorption maxima increases in 
intensity. Such spectral changes with observed red shift indicate intercalative mode of 
binding with calf thymus DNA and are attributed to "Hyperchromic effect". 
The kinetics is further studied by observed pseudo first-order rate constants, kobs, value, 
as they can be directly compared and used as a measure of the kinetic influence from 
surrounding DNA [336], The observed rate constant 1.77 S-' for guanine bound complex 
which is of large magnitude in comparison to k^bs, 1 -52 s"' value for calf thymus DNA 
bound complex. The rate constant for adenine bound complex is 0.94 s"' which is much 
slow in comparison to guanine and calf thymus DNA (Figure 48). The complex shows 
preference for guanine over adenine due to two effects. When adenine binds only a weak 
hydrogen bound forms between the chloride ligand of the complex and H2N-C6 group of 
adenine, secondly, a significantly stronger molecular orbital interaction is identified 
compared to adenine. These studies are well in agreement with the interaction of cisplatin 
with to purine bases by Lippard et al. [337]. These studies are well is agreement with the 
interaction of cisplatin Our investigations show that the complex 
C32H34N4S203BCuSn2Cl5 is strongly bound to calf thymus DNA through two different 
modes. Cu(II) prefers to bind strongly to N7 of guanine base while the Sn'^atom is only 
bound to nucleotides via. the phosphate group. Moreover, the affinity of Sn'^ with 
dinegative phosphate group is very strong due to its hard Lewis acidic nature. The 
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Figure 44. Absorption spectra of (a) guanine (1 x 10'^ M) dissolved in 9.2 pH buffer in 
absence of the complex (b) interaction of complex C32Hi4N4S20sBCuSn2Cls 
with increasing amount of guanine. 
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Figure 45. Absorption spectra of (a) adenine (1 x 10'^ M) dissolved in distilled water in 
absence of the complex (b) interaction of complex C}2Hs4N4S203BCuSn2Cls 
with increasing amount of adenine. 
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Figure 46. Absorption spectra of (a) calf thymus DNA (2.5 x 10'^ M) dissolved in 7.5 
pH tris HCl buffer in absence of the complex (b) interaction of complex 
C32H34^4S20sBCuSn2Cls with increasing amount of calf thymus DNA. 
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Figure 47 (a). Plot of absorbance versus time at different concentrations of guanine. 
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Figure 47 (b). Plot of absorbance versus time at different concentrations of adenine 
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Figure 47 (c). Plot of absorhance versus time at different concentrations of calf thymus 
DMA. 
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Figure 48. (a) Plot ofkots versus [guanine], (b) kobs versus [adenine] and (c) ^obs versus 
[calf thymus DNA]. 
binding to guanine is also kineticaliy preferred and supported by large kobs, value 
(1.77 s"') for guanine bound complex. 
Thus in conclusion, the complex C32H34N4S203BCuSn2Cl5 may first bind with phosphate 
group of calf thymus DNA, neutralize the negative charge of calf thymus DNA phosphate 
group, and cause contraction and conformation change of calf thymus DNA which is 
clearly evidenced by the "over all" hyperchromic effect observed in the absorption 
spectra. 
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CHAPTER VI 
Synthesis, charactenzation. Synthesis, characterization of 
new Cu(II)/Ni(II) complexes of 2-mercaptobenzintidazole 
derivative* Antibacterial, antifungal and interaction of 
Cu(II) complex with calf thymus DNA, 
CHAPTER VI 
E x p e r i m e n t a l 
2-Mercaptobenzimidazole (Fluka), diethyl oxalate, NiCl2 6H20 and CUCI2.2H2O 
ethylenediamine (Merck) were used as received. Microanalyses of the complexes were 
obtained on a Carlo Erba Analyzer Model 1106. Molar conductances were measured at 
room temperature on a Digisun Electronic Conductivity Bridge. I.r. spectra 
(200-4000 cm ') were recorded on a Carl Ziess specord M-80 spectrophotometer in nujol 
mulls 'H and '^C n.m.r. spectra were recorded on an amx-500 instrument. The e.p.r. 
spectra were obtained on a Varian El 12 spectrometer at X-band frequency (9.1 GHz) at 
liquid nitrogen temperature (LNT). 
The electrochemical behaviour of the Cu(II) complex and its interaction with calf thymus 
DNA were monitored by cyclic voltammetry in DMSO/H2O (5: 95) solvent. The kinetic 
experiments were performed under pseudo-first order conditions and the spectral changes 
were recorded at 260 nm of calf thymus DNA) with respect to time using a 
(USB2000) Ocean Optics spectrophotometer. Viscosity measurements were carried out 
using Ostwald's \i.scomcter at 29±0.0l''C. Flow time was measured with a digital stop-
watch. Each sample was measured three times and an average flow time was calculated. 
Data \\ere presented as (n/r) 0) versus binding ratio ([Cu]/[DNA]) [338], where t] is a 
viscosity of DNA in the presence of complex and rjo is the viscosity of DNA alone. 
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Viscosity values were calculated from the observed flow time of DNA containing 
solution (t >100s) corrected for the flow time of buffer alone (to), T] = t- to 
Antibacterial screening 
The antibacterial activity of the test compounds, were screened against E. coli and S. 
aureus in DMSO by the well diffusion method using standard Mueller-hinton agar as the 
medium [264], 
Sensitivity plates were inoculated with E-coli and S. aureus and the well was loaded with 
(140 1^ 1) of test compound solution using a micropipette. The incubation was done for 
24h. at 37°C. During this period, the test solution diffused zones of inhibition which were 
recorded using Vernier callipers. The radius of the zone is the measure of antibacterial 
activity. 
To evaluate the effect of concentration on antibacterial activity, four different 
concentrations (10, 20, 30 and 40 mg/ml) of the test compounds were screened against 
E. coli and S. aureus in DMSO by employing the same procedure. 
Antifungal screening 
Antifungal activity of the test compounds were evaluated using the Sabouroud dextrose 
agar diffusion method. Wells were made (8 mm diameter) with a sterile cork borer. To 
these wells 140 jil from each (10, 20, 30 and 40 mg/ml) of the test stock solution 
compounds were added and the plates were allowed to cool for an hour to facilitate the 
diffusion. The plates were then incubated at 37° C for 48h. At the end of the incubation 
period, the diameter of the zone of inhibition around the wells was measured. 
Synthesis of ligand [LJ. 
2-mercaptobenzimidazole (5 g, 0.033 mol) was dissolved in MeOH (100 mL) and to this 
solution was added diethyl oxalate (2.26 g, 0.016 mol) in a 2:1 molar ratio. The solution 
was refluxed for ca. 1 h, then conc. HCI (6 mL) was added dropwise with constant 
stirring. The cream crystalline product which formed was filtered off under vacuum, 
washed thoroughly with hexane and dried in vacuo. 
Synthesis of [Cu(en)2l.Cl2 and [Ni(en)2].Cl2 
These compounds were synthesized by the method reported earlier [290]. 
Synthesis of the [C2oH22S2N8Cu].Cl2 
To a solution of the ligand (Ig, 0.003 mol) in MeOH (50 mL) was added [Cu(en)2].Cl2 
(0.76 g 0.003 mol) in the same solvent. The resulting mixture was magnetically stirred 
for ca. 2 h. The blue precipitate formed was isolated, washed with hexane and dried in 
vacuo. 
Synthesis of the [CjoHajSjNsNiJ.Cb 
A MeOH solution of the ligand L (1 g, 0.003 mol) and [Ni(en)2].Cl2 (0.746 g, 0.003 mol) 
was stirred for ca. 3 h. A green precipitate, obtained after keeping the solution overnight at 
room temperature, was filtered off, washed with hexane and dried in vacuo. 
Result and discussion 
Lr. spectrum 
The ligand L shows a medium intensity band at 2474 cm"' assigned to -S-H group, which 
remains unaltered suggesting the noninvolvement of this group in coordination with 
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diethyl oxalate [339], The characteristic bands at 3100 and 1490 cm'' due to X)(N-H) 
stretching and bending vibration [340], respectively were not observed in i.r. spectrum of 
ligand indicating the ligand formation take place through - N H group of imidazole ring. 
In the compiexes, the characteristic band at ca. 1688 cm"' attributed to D(C=0) disappears 
[341], with the emergence of a new strong band at 1639-1645 cm ' region which 
indicates the condensation of u(C=0) group with NH2 group of, bis(ethylenediamine) 
Cu"/Ni" complexes. The formation of u(C=N) band, and the disappearance of the u(C=0) 
band in the complexes are indicative of effective Schi f f s base condensation [342]. The 
alkyl CH2 group show characteristic stretching absorption bands in the region 2942, 
deformation band at 1508 and rocking modes at 677 cm"' respectively [343]. A medium 
intensity band at 3357 cm"' was observed in the complexes which was assigned to uCNHi) 
groups of the other side of bis(ethylenediamine) moiety suggesting!:! condensation 
reaction [344]. 
In the far i.r. region, the bands appearing at 425 and 445 cm"' are assigned to u(Cu-N) 
and \)(Ni-N), which further confirm the formation of the complexes. [345] (Table 17). 
Electronic spectra 
The electronic spectrum of the copper(II) complex in DMSO reveals a broad band at ca. 
14,705 cm"' assignable to ^Big — • ^Aig transition [346, 299] which is characteristic of 
square planar environment around the copper(Il) ion (Figure 49). The nickel(ll) complex 
displays two bands at ca. 17,000 and 24,075 cm"' regions which are assigned to 
' A I ( F ) • ' B I ( G ) and ' A i g — • ' A i g transitions respectively, characteristic of typical 
1 1 9 
square-planar geometry [347], which is also in well agreement with e.p.r. spectral studies 
at LNT. A strong charge transfer (LMCT) band at ca. 36,673 and 30,000 cm"' region 
appears in all the complexes attributed to the n-n* transition [348, 349]. 
500 600 
Wavelength (nm) 
Figure 49. The representative electronic spectra of Cu(II) complex. 
N .M.R. spectra 
In order to elucidate the structural features of the compounds, 'H and '^C n.m.r spectra 
of the ligand [C16H10O2N4S2] and the complex [C2oH22N8S2Ni]Cl2, recorded in D2O and 
DMSO, respectively were examined. The 'H n.m.r. spectrum of ligand, exhibits a intense 
signals a( 3.8 p.p.m. which were assigned to - S H protons [350], The absence of band at 
ca. 12 p.p.m. due to NH protons suggests deprotonation of - N H group of the imidazole 
ring. In addition, the spectrum of the ligand exhibits multiplet at 7.73-7.85 p.p.m., which 
shows the presence of phenyl protons [351]. The '^C n.m.r. spectrum of the ligand 
120 
exhibits signals at 165.70 and 128.0 p.p.m. assigned to > C = 0 group and phenyl carbons, 
respectively. 
The 'H n.m.r. spectrum of the [C2oH22N8S2Ni]Cl2 complex displays signals at 5.2 and 
3.7-3.84 p.p.m. due to -NH2 and -CH2 protons, respectively [352,353]. These signals 
further support the formation of complex by 1:1 condensation reaction. The '^C n.m.r. 
spectrum of the complex strongly supports the Schiff base formation as signal assigned to 
> C = 0 at 165.70 disappears and two new signals were observed at 170 and 49.2 p.p.m. 
attributed to >C=N and -NCH2 carbons, respectively (Table 18 and 19). 
E .p . r . S p e c t r a 
The X-Band (w9.1 GHz) e.p.r spectrum of the complex [C2oH22N8S2Cu]Cl2 was recorded 
at liquid nitrogen temperature (77k) using tetracynoethylene (TCNE), as field marker. 
I\ 
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Figure 50. X-bandEPR spectra of the Cu(JI)complex at LNT. 
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The g||_ gi and gav values computeci from the spectrum were found to be 2.22, 2.07 and 
2.11, respectively. The mathematical expression for gav value is gav^=(g!i^+2g±^)/3. The 
existence of gi i>gi suggest that dx^-y^ is the ground state with the d^ [Cu^" ]^ configuration 
i.e. (eg)"*, (aig)^ (b2g)^  (big), which evidences the square planar environment around the 
copper(II) ion in the complex [280] (Figure 50). 
Elec t rochemis t ry 
The cyclic voltammetry of the copper(II) complex was recorded in DMSO/H2O (5:95) at 
room temperature at a scan rate of 0.2 Vs"' in the potential rang 1.0 to -0.8 V (Figure 51). 
The cyclic voltammogram of the copper(II) complex in absence of calf thymus DNA 
exhibits a quasireversible redox wave for one electron transfer process corresponding to 
Cu'VCu' redox couple with E,/2 = 27 mV and AEp value of 288 mV [254]. The ratio of 
the anodic and cathodic peak currents Ipa/Ipc is 1.33 implying quasireversible electron 
transfer. At different scan rates, the voltammogram does not show any major change. 
However, at various scan rates the peak height increases indicating the reversibility of the 
process (Figure 52). 
On addition of calf thymus DNA, copper (11) complex registers a significant shift in AEp 
value as well as in E\a values 105 and 17 mV, respectively at the scan rate of 0.2 Vs"' 
(Figure 53). The ratio of Ipa/Ipc = 0.67 for the calf thymus bound complex. The decrease 
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in current is due to diffusion of an equilibrium mixture of free and DNA-bound metal 
complex to the electrode surface [134], 
- 0 2 
- 0 6 
- 1 0 
- 1 2 I 
Figure 51. Cyclic voltammogram of Cu(II) complex in DMSO/H2O (5:95) at 3(fC at a 
scan rate of 0.2 Vs''. 
Figure 52. Cyclic voltammograms of Cu(Il) complex in DMSO/H2O (5:95) at SO^C at 
different scan rates viz. 0.2, 0.3 and 0.4 Vs''. 
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Figure 52. Cyclic voltammogram of Cu(II) complex in the presence of calf thymus DNA 
at 30"C at a scan rale of 0 2 Vs' 
To elucidate the binding mechanism involving the Cu(II) or Cu(I) forms of complex to 
calf thymus DNA, the net shift in E\a can be used to estimate the ratio of equilibrium 
constants by the following equation 
Cu" + e 
/ 
Cu"-CTDNA+e" 
Cu' 
K , . 
Cu ' -CTDNA 
1 2 4 
e I ^ - E " ^ ' = 0.0591 log(Ki+/K2+) 
The ratio of binding constants o f + 1 and +2 species was (0.9) close to 1, suggesting that 
both Cu(II) and Cu(I) forms interact with CTDNA to the same extent. 
Kinetics studies 
The binding studies of the copper(II) complex with calf thymus DNA were recorded 
spectrophotometrically at 30°C performed in Trisbuffer/DMSO solution at 260 nm (X a^x 
of calf thymus DNA) under pseudo first order conditions. Different set of the kinetics 
measurements were carried out at a fixed concentration of copper(II) complex 
(1 x 10'^  M) with varying concentration of calf thymus DNA (1-1.6 x 10"^  M). The 
spectral changes were monitored with respect to time and depicted in Figure 54. 
On interaction with calf thymus DNA, the absorption spectrum displays a large red shift 
ca. 14 nm and decrease in absorption intensity (hypochromism) with two isobestic points 
at 250 and 310 nm. These results are similar to those reported earlier for various 
metallointercalators [355] and suggest that the copper(II) complex bind strongly to calf 
thymus DNA through intercalation mode. The rate constant, k^ bs, were obtained by the 
linear least squares regression method (Figure 55). On the basis of kinetic data, the 
following mechanism, is proposed. 
The following rate law has been derived 
Khs= k,k2[DNA]/[k., + k2] (1) 
125 
3 0 0 AOO 
Wavelength 
5 0 0 
Figure 54(a). Electronic spectra of the Cu(II) complex in the presence of calf thymus 
DNA with respect to time at 1 x 10'^ M. 
• - ( ] X 10) X 10-' [DNA] mol d m ' 
• - ( 1 X 12) X 10-5 P N A ] mol dm-^ 
iir-(l X 14) X 10-' [DNA] mol dm'^ 
10 15 
Time(rain.) 
20 
Figure 45 (b). Plot of-logA versus time for [C20H22S2N8CUJ.CI2 at varying concentration 
of calf thymus DNA (1-1.6 x 10'^ mol dm'^). 
1 2 6 
tA 
i m 
[DNA] 10'^ mol dm ^ 
Figure 55 b. Plot ofkots versus DNA for the complex [CynHnS^NgCuJ.Ch at the varying 
concentration of calf thymus DNA (1 0-1 6 x 10^ mol Jm'^). Fixed 
concentration of the complex [C2nf^22-^:NgCuJ CI 2 = 0 1 x 10'^ mol dm'^) 
1 2 7 
If the above rate law holds good, the proposed mechanism (scheme 5) is correct. The plot 
of kobs, versus [DNA] gave a straight line with slope = kik2[k -i+ka] which is consistent 
with the proposed mechanism. 
+ S 
ki 
- N 
- S H 
• N 
A^/Iaa/^  
Scheme 5 
k2 DNA 
1 2 8 
Viscosity Measurements 
To further clanfy the nature of the interaction between the complex and DNA, viscosity 
measurements were carried out and the results are presented in Figure 56 The expenment 
involves the measurement of the flow rate of DNA solution through a capillary 
viscometer. Hydrodynamic measurement that are sensitive to length change (i e viscosity 
and sedimentation) are regarded as the least ambiguous and most critical tests of a 
binding model m solution m the absence of crystallographic structural data [356,357] 
The complex [C2oH22N8S2Cu]Cl2 proved to be very interesting species as it increase the 
viscosity of the calf thymus DNA by varymg concentration of added complex, signifying 
that Cu(II) complex binds to DNA through partial intercalation mode Partial 
intercalation may act as a wedge to try apart one of a base-pair stack, but not fiilly 
separate the stack as required by the classical intercalation mode 
0.1 0.2 0.3 
l/R(=[Cu]/DNA) 
Figure 56. Effect of increasing amount ofCu(ll) complex on the relative viscosity ofCTDNA at 
25±0.J°C. [DNA] = 5x10^ 
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Ant ibac ter ia l Activity 
Among the compounds tested, the copper(II) complex [C2oH22N8S2Cu]Cl2 was found to 
be the most active against S. aureus and E. coli (Table 20). The activity of the copper(II) 
complex can be attributed to hydrogen bond formation between the nitrogen (>C=N) 
atom of the complex and some bioreceptors in the cells of the bacteria, which in turn the 
block of the synthesis of proteins by inhibiting the movement of ribosome along with 
RNA [358]. This inhibhs the synthesis of DNA in the cell nucleus. The order of 
inhibition was found to be: 
Mercaptobenzimidazole < [C16H10O2N4S2] < [Cu(en)2].Cl2 < [C2oH22N8S2N8Cu]Cl2. 
F igure 57. Inhibition zones of the test compounds: 2-mercaptobenzimidazole (1), 
[C,6H,o02N4S2] (2), [Cu(en)2].Cl2 (3),[C2oH22N8S2N8Cu]Cl2(4) and DMSO 
(5) against E. coli. 
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Antifungal activity 
The results of antifungal studies are presented in Table 21. The results shows that the 
complex [C2oH22N8S2Cu]Cl2 is more toxic in comparison to the other compounds against 
the same micro-organisms and under the identical experimental conditions. The increase 
in antifungal activity of the complex [C2oH22N8S2Cu]Cl2 can be ascribed to the effect of 
the metal ion on the normal cell process. The toxicity increase in the light of chelation 
theory [359, 360] as chelation considerably reduces the polarity of the metal ion mainly 
because of partial sharing of its positive charge with donor groups and possible 
Ti-delocalisation over the chelation ring. Such chelation could enhance the lipophilic 
character of the central metal atom, which subsequently favours its permeation through 
the lipid layer of the cell membrane. Furthermore, the mechanism of the compounds may 
involve the formation of hydrogen bonds through the uncoordinated heteroatoms as 0 , S, 
and N with the active centers of the cell constituents resulting in interference with the 
normal cell processes. The presence of lipophilic and polar substituents such as C=N, 
S-H and NH2 are expected to enhance the fungal toxicity and therefore these copper(ll) 
complex have a greater chance of interaction with the nucleotide bases. 
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